UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~September 30, 2022

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number	State of Incorporation or Organization	I.R.S. Employer Identification No.
001-32427	Huntsman Corporation 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	42-1648585
333-85141	Huntsman International LLC 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	87-0630358

Securities registered pursuant to Section 12(b) of the Act:

Registrant	Title of each class	Trading Symbol	Name of each exchange on which registered
Huntsman Corporation	Common Stock, par value $0.01 per share	HUN	New York Stock Exchange
Huntsman International LLC	NONE	NONE	NONE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Huntsman Corporation	Large accelerated filer ☒	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company ☐	Emerging growth company ☐
Huntsman International LLC	Large accelerated filer ☐	Accelerated filer ☐	Non-accelerated filer ☒	Smaller reporting company ☐	Emerging Growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Huntsman Corporation		☐
Huntsman International LLC		☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Huntsman Corporation	Yes ☐	No ☒
Huntsman International LLC	Yes ☐	No ☒

On ~~April 20,~~October 25, 2022, ~~209,798,078~~192,099,455 shares of common stock of Huntsman Corporation were outstanding and 2,728 units of membership interests of Huntsman International LLC were outstanding. There is no trading market for Huntsman International LLC’s units of membership interests. All of Huntsman International LLC’s units of membership interests are held by Huntsman Corporation.

This Quarterly Report on Form 10-Q presents information for two registrants: Huntsman Corporation and Huntsman International LLC. Huntsman International LLC is a wholly-owned subsidiary of Huntsman Corporation and is the principal operating company of Huntsman Corporation. The information reflected in this Quarterly Report on Form 10-Q is equally applicable to both Huntsman Corporation and Huntsman International LLC, except where otherwise indicated. Huntsman International LLC meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q and, to the extent applicable, is therefore filing this form with a reduced disclosure format.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD

ENDED ~~March 31,~~September 30, 2022

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION	4
ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)	4
	Huntsman Corporation and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	4
	Unaudited Condensed Consolidated Statements of Operations	5
	Unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income	6
	Unaudited Condensed Consolidated Statements of Equity	67
	Unaudited Condensed Consolidated Statements of Cash Flows	89
	Huntsman International LLC and Subsidiaries:
	Unaudited Condensed Consolidated Balance Sheets	9
	~~Condensed Consolidated Statements of Operations~~	10
	Unaudited Condensed Consolidated Statements of ~~Comprehensive Income~~Operations	11
	Unaudited Condensed Consolidated Statements of ~~Equity~~Comprehensive (Loss) Income	12
	Unaudited Condensed Consolidated Statements of Equity	13
	Unaudited Condensed Consolidated Statements of Cash Flows	1314
	Huntsman Corporation and Subsidiaries and Huntsman International LLC and Subsidiaries:
	Notes to Unaudited Condensed Consolidated Financial Statements	1415
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3336
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	4654
ITEM 4.	Controls and Procedures	4654
PART II	OTHER INFORMATION	4755
ITEM 1.	Legal Proceedings	4755
ITEM 1A.	Risk Factors	4755
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	4755
ITEM 6.	Exhibits	4856

Table of Contents

FORWARD-LOOKING STATEMENTS

Certain information set forth in this report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; projected impact of COVID-19 on our operations and future financial results; projected impact of the potential expansion of the Russia-Ukraine conflict on our operations and future financial results; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, business separations, spin-offs, or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. We may also make additional forward-looking statements from time to time. All such subsequent forward-looking statements, whether written or oral, by us or on our behalf, are also expressly qualified by these cautionary statements.

All forward-looking statements, including without limitation any projections derived from management’s examination of historical operating trends, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them, but there can be no assurance that management’s expectations, beliefs and projections will be achieved. All forward-looking statements apply only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether because of new information, future events or otherwise, except as required by securities and other applicable law.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this report. Any forward-looking statements should be considered in light of the risks set forth in “Part II. Item 1A. Risk Factors” below and “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021.

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Share and Per Share Amounts)

	*March 31,*			*December 31,*			*September 30,*			*December 31,*
	*2022*			*2021*			*2022*			*2021*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	807		$	1,041		$	515		$	1,041
Accounts and notes receivable (net of allowance for doubtful accounts of $23 and $25, respectively), ($372 and $324 pledged as collateral, respectively)(a)		1,285			1,159
Accounts and notes receivable (net of allowance for doubtful accounts of $11 and $12, respectively), ($348 and $324 pledged as collateral, respectively)(a)								981			988
Accounts receivable from affiliates		25			27			23			27
Inventories(a)		1,382			1,201			1,079			1,038
Receivable associated with the Albemarle Settlement		333			333			—			333
Other current assets		156			167			115			155
Current assets held for sale								483			346
Total current assets		3,988			3,928			3,196			3,928
Property, plant and equipment, net(a)		2,551			2,576			2,288			2,443
Investment in unconsolidated affiliates		485			470			430			470
Intangible assets, net		461			469			433			469
Goodwill		650			650			636			650
Deferred income taxes		204			206			167			180
Operating lease right-of-use assets		390			403			359			381
Other noncurrent assets(a)		673			690			623			689
Noncurrent assets held for sale								—			182
Total assets	$	9,402		$	9,392		$	8,132		$	9,392

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	1,252		$	1,148		$	865		$	1,054
Accounts payable to affiliates		63			60			33			60
Accrued liabilities(a)		732			780			393			713
Current portion of debt(a)		21			12			12			12
Current operating lease liabilities(a)		50			51			50			49
Current liabilities held for sale								242			163
Total current liabilities		2,118			2,051			1,595			2,051
Long-term debt(a)		1,529			1,538			1,476			1,538
Deferred income taxes		178			161			249			161
Noncurrent operating lease liabilities(a)		358			370			326			346
Other noncurrent liabilities(a)		679			713			502			586
Noncurrent liabilities held for sale								—			151
Total liabilities		4,862			4,833			4,148			4,833
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman Corporation stockholders’ equity:
Common stock $0.01 par value, 1,200,000,000 shares authorized, 261,055,993 and 259,701,770 shares issued and 209,975,156 and 214,170,287 shares outstanding, respectively		3			3
Common stock $0.01 par value, 1,200,000,000 shares authorized, 261,142,535 and 259,701,770 shares issued and 192,757,360 and 214,170,287 shares outstanding, respectively								3			3
Additional paid-in capital		4,152			4,102			4,155			4,102
Treasury stock, 51,080,837 and 45,531,489 shares, respectively		(1,144	)		(934	)
Treasury stock, 68,385,175 and 45,531,489 shares, respectively								(1,686	)		(934	)
Unearned stock-based compensation		(49	)		(25	)		(37	)		(25	)
Retained earnings		2,595			2,435			2,836			2,435
Accumulated other comprehensive loss		(1,214	)		(1,203	)		(1,497	)		(1,203	)
Total Huntsman Corporation stockholders’ equity		4,343			4,378			3,774			4,378
Noncontrolling interests in subsidiaries		197			181			210			181
Total equity		4,540			4,559			3,984			4,559
Total liabilities and equity	$	9,402		$	9,392		$	8,132		$	9,392

(a)

At ~~March 31,~~September 30, 2022 and December 31, 2021, respectively, $9$22 and $1 of cash and cash equivalents, $9$4 and $12 of accounts and notes receivable (net), ~~$66~~$60 and $64 of inventories, ~~$156 and~~ $161 each of property, plant and equipment (net), ~~$25~~$29 and $23 of other noncurrent assets, ~~$145~~$126 and $146 of accounts payable, $8$11 and $13 of accrued liabilities, ~~$17 and~~ $10 each of current portion of debt, $10 and $6 ~~each~~ of current operating lease liabilities, ~~$33~~$28 and $35 of long-term debt, ~~$19~~$21 and $20 of noncurrent operating lease liabilities and $45 and $46 ~~each~~ of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions, Except Per Share Amounts)

	*Three months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*
	*March 31,*						*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*			*2022*			*2021*
Revenues:
Trade sales, services and fees, net	$	2,329		$	1,802		$	1,946		$	2,042		$	6,189		$	5,418
Related party sales		60			35			65			55			184			140
Total revenues		2,389			1,837			2,011			2,097			6,373			5,558
Cost of goods sold		1,824			1,445			1,662			1,660			5,017			4,397
Gross profit		565			392			349			437			1,356			1,161
Operating expenses:
Selling, general and administrative		216			207			165			176			532			536
Research and development		38			38			31			35			97			102
Restructuring, impairment and plant closing costs		0			24
Other operating expenses (income), net		7			(3	)
Restructuring, impairment and plant closing costs (credits)								12			(1	)		36			34
Gain on sale of India-based DIY business								—			—			—			(28	)
Other operating expense (income), net								3			(3	)		(8	)		(13	)
Total operating expenses		261			266			211			207			657			631
Operating income		304			126			138			230			699			530
Interest expense, net		(14	)		(19	)		(16	)		(15	)		(46	)		(52	)
Equity in income of investment in unconsolidated affiliates		15			38			21			34			55			118
Fair value adjustments to Venator investment		(2	)		(19	)
Fair value adjustments to Venator investment, net								(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt								—			—			—			(27	)
Other income, net		1			7			10			7			23			21
Income from continuing operations before income taxes		304			133			146			253			722			562
Income tax expense		(65	)		(34	)		(30	)		(34	)		(155	)		(101	)
Income from continuing operations		239			99			116			219			567			461
Income from discontinued operations, net of tax		1			1
(Loss) income from discontinued operations, net of tax								(1	)		6			30			36
Net income		240			100			115			225			597			497
Net income attributable to noncontrolling interests		(17	)		(17	)		(15	)		(16	)		(46	)		(49	)
Net income attributable to Huntsman Corporation	$	223		$	83		$	100		$	209		$	551		$	448

Basic income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders	$	1.04		$	0.38		$	0.52		$	0.93		$	2.54		$	1.87
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0.01			0
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax								(0.01	)		0.02			0.15			0.16
Net income attributable to Huntsman Corporation common stockholders	$	1.05		$	0.38		$	0.51		$	0.95		$	2.69		$	2.03
Weighted average shares		212.7			220.4			197.7			219.4			205.2			220.2

Diluted income per share:
Income from continuing operations attributable to Huntsman Corporation common stockholders	$	1.03		$	0.37		$	0.51		$	0.92		$	2.52		$	1.86
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0.01			0
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax								(0.01	)		0.02			0.14			0.16
Net income attributable to Huntsman Corporation common stockholders	$	1.04		$	0.37		$	0.50		$	0.94		$	2.66		$	2.02
Weighted average shares		215.4			222.6			199.2			221.3			207.2			222.2

Amounts attributable to Huntsman Corporation:
Income from continuing operations	$	222		$	82		$	101		$	203		$	521		$	412
Income from discontinued operations, net of tax		1			1
(Loss) income from discontinued operations, net of tax								(1	)		6			30			36
Net income	$	223		$	83		$	100		$	209		$	551		$	448

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(In Millions)

Three months

ended

March 31,

2022

2021

Net income
$ 240 $ 100
Other comprehensive loss, net of tax:

Foreign currency translations adjustments
(20 ) (32 )
Pension and other postretirement benefits adjustments
9 19
Other, net
(1 ) 0
Other comprehensive loss, net of tax
(12 ) (13 )
Comprehensive income
228 87
Comprehensive income attributable to noncontrolling interests
(16 ) (17 )
Comprehensive income attributable to Huntsman Corporation
$ 212 $ 70

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Net income	$	115		$	225		$	597		$	497
Other comprehensive (loss) income, net of tax:
Foreign currency translations adjustments		(204	)		(36	)		(338	)		(42	)
Pension and other postretirement benefits adjustments		10			17			28			52
Other, net		—			—			(1	)		—
Other comprehensive (loss) income, net of tax		(194	)		(19	)		(311	)		10
Comprehensive (loss) income		(79	)		206			286			507
Comprehensive loss (income) attributable to noncontrolling interests		(6	)		(17	)		(29	)		(51	)
Comprehensive (loss) income attributable to Huntsman Corporation	$	(85	)	$	189		$	257		$	456

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Share Amounts)

	*Huntsman Corporation Stockholders' Equity*																									*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*																									*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*						*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*			*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*			*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2022		214,170,287		$	3	$	4,102	$	(934	)	$	(25	)	$	2,435		$	(1,203	)	$	181		$	4,559			214,170,287		$	3	$	4,102	$	(934	)	$	(25	)	$	2,435		$	(1,203	)	$	181		$	4,559
Net income		—			0		0		0			0			223			0			17			240			—			—		—		—			—			223			—			17			240
Other comprehensive loss		—			0		0		0			0			0			(11	)		(1	)		(12	)		—			—		—		—			—			—			(11	)		(1	)		(12	)
Issuance of nonvested stock awards		—			0		32		0			(32	)		0			0			0			0			—			—		32		—			(32	)		—			—			—			—
Vesting of stock awards		1,327,568			0		7		0			0			0			0			0			7			1,327,568			—		7		—			—			—			—			—			7
Recognition of stock-based compensation		—			0		1		0			8			0			0			0			9			—			—		1		—			8			—			—			—			9
Repurchase and cancellation of stock awards		(361,250	)		0		0		0			0			(13	)		0			0			(13	)		(361,250	)		—		—		—			—			(13	)		—			—			(13	)
Stock options exercised		387,899			0		10		0			0			(5	)		0			0			5			387,899			—		10		—			—			(5	)		—			—			5
Treasury stock repurchased		(5,549,348	)		0		0		(210	)		0			0			0			0			(210	)		(5,549,348	)		—		—		(210	)		—			—			—			—			(210	)
Dividends declared on common stock ($0.2125 per share)		—			0		0		0			0			(45	)		0			0			(45	)		—			—		—		—			—			(45	)		—			—			(45	)
Balance, March 31, 2022		209,975,156		$	3	$	4,152	$	(1,144	)	$	(49	)	$	2,595		$	(1,214	)	$	197		$	4,540			209,975,156			3		4,152		(1,144	)		(49	)		2,595			(1,214	)		197			4,540
Net income																											—			—		—		—			—			228			—			14			242
Other comprehensive loss																											—			—		—		—			—			—			(98	)		(7	)		(105	)
Vesting of stock awards																											4,045			—		—		—			—			—			—			—			—
Recognition of stock-based compensation																											—			—		1		—			8			—			—			—			9
Repurchase and cancellation of stock awards																											(2,416	)		—		—		—			—			(1	)		—			—			(1	)
Stock options exercised																											66,840			—		1		—			—			—			—			—			1
Treasury stock repurchased																											(8,371,423	)		—		—		(291	)		—			—			—			—			(291	)
Dividends declared on common stock ($0.2125 per share)																											—			—		—		—			—			(44	)		—			—			(44	)
Balance, June 30, 2022																											201,672,202			3		4,154		(1,435	)		(41	)		2,778			(1,312	)		204			4,351
Net income																											—			—		—		—			—			100			—			15			115
Other comprehensive loss																											—			—		—		—			—			—			(185	)		(9	)		(194	)
Vesting of stock awards																											10,174			—		—		—			—			—			—			—			—
Recognition of stock-based compensation																											—			—		1		—			4			—			—			—			5
Repurchase and cancellation of stock awards																											(2,533	)		—		—		—			—			—			—			—			—
Stock options exercised																											10,432			—		—		—			—			—			—			—			—
Treasury stock repurchased																											(8,932,915	)		—		—		(251	)		—			—			—			—			(251	)
Dividends declared on common stock ($0.2125 per share)																											—			—		—		—			—			(42	)		—			—			(42	)
Balance, September 30, 2022																											192,757,360		$	3	$	4,155	$	(1,686	)	$	(37	)	$	2,836		$	(1,497	)	$	210		$	3,984

Huntsman Corporation Stockholders' Equity

Accumulated

Shares

Additional

Unearned

other

Noncontrolling

Common

Common

paid-in

Treasury

stock-based

Retained

comprehensive

interests in

Total

stock

stock

capital

stock

compensation

earnings

loss

subsidiaries

equity

Balance, January 1, 2021
220,046,262 $ 3 $ 4,048 $ (731 ) $ (19 ) $ 1,564 $ (1,346 ) $ 154 $ 3,673
Net income
— 0 0 0 0 83 0 17 100
Other comprehensive loss
— 0 0 0 0 0 (13 ) 0 (13 )
Issuance of nonvested stock awards
— 0 25 0 (25 ) 0 0 0 0
Vesting of stock awards
664,818 0 5 0 0 0 0 0 5
Recognition of stock-based compensation
— 0 2 0 6 0 0 0 8
Repurchase and cancellation of stock awards
(202,961 ) 0 0 0 0 (6 ) 0 0 (6 )
Stock options exercised
204,005 0 5 0 0 (2 ) 0 0 3
Dividends declared on common stock ($0.1625 per share)
— 0 0 0 0 (36 ) 0 0 (36 )
Balance, March 31, 2021
220,712,124 $ 3 $ 4,085 $ (731 ) $ (38 ) $ 1,603 $ (1,359 ) $ 171 $ 3,734

~~See accompanying notes to condensed consolidated financial statements.~~

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~CASH FLOWS~~EQUITY

(In ~~Millions)~~Millions, Except Share Amounts)

Three months

ended

March 31,

2022

2021

Operating Activities:

Net income
$ 240 $ 100
Less: Income from discontinued operations, net of tax
(1 ) (1 )
Income from continuing operations
239 99
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities from continuing operations:

Equity in income of investment in unconsolidated affiliates
(15 ) (38 )
Unrealized losses on fair value adjustments to Venator investment
2 19
Depreciation and amortization
71 74
Noncash lease expense
16 17
Noncash restructuring and impairment charges
0 8
Deferred income taxes
13 0
Stock-based compensation
11 9
Other, net
1 2
Changes in operating assets and liabilities:

Accounts and notes receivable
(134 ) (117 )
Inventories
(187 ) (156 )
Other current assets
16 (10 )
Other noncurrent assets
(1 ) (30 )
Accounts payable
120 94
Accrued liabilities
(41 ) 20
Other noncurrent liabilities
(26 ) (7 )
Net cash provided by (used in) operating activities from continuing operations
85 (16 )
Net cash used in operating activities from discontinued operations
0 (1 )
Net cash provided by (used in) operating activities
85 (17 )

Investing Activities:

Capital expenditures
(69 ) (98 )
Acquisition of business, net of cash acquired
0 (240 )
Cash received from sale of business
0 15
Other, net
4 0
Net cash used in investing activities
(65 ) (323 )

Financing Activities:

Net borrowings on revolving loan facilities
8 9
Repayments of long-term debt
(3 ) (548 )
Dividends paid to common stockholders
(46 ) (37 )
Repurchase and cancellation of awards
(13 ) (6 )
Repurchase of common stock
(203 ) 0
Proceeds from issuance of common stock
5 3
Net cash used in financing activities
(252 ) (579 )
Effect of exchange rate changes on cash
(2 ) (1 )
Decrease in cash and cash equivalents
(234 ) (920 )
Cash and cash equivalents at beginning of period
1,041 1,593
Cash and cash equivalents at end of period
$ 807 $ 673

Supplemental cash flow information:

Cash paid for interest
$ 9 $ 16
Cash paid for income taxes
32 8

	*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2021		220,046,262		$	3	$	4,048	$	(731	)	$	(19	)	$	1,564		$	(1,346	)	$	154		$	3,673
Net income		—			—		—		—			—			83			—			17			100
Other comprehensive loss		—			—		—		—			—			—			(13	)		—			(13	)
Issuance of nonvested stock awards		—			—		25		—			(25	)		—			—			—			—
Vesting of stock awards		664,818			—		5		—			—			—			—			—			5
Recognition of stock-based compensation		—			—		2		—			6			—			—			—			8
Repurchase and cancellation of stock awards		(202,961	)		—		—		—			—			(6	)		—			—			(6	)
Stock options exercised		204,005			—		5		—			—			(2	)		—			—			3
Dividends declared on common stock ($0.1625 per share)		—			—		—		—			—			(36	)		—			—			(36	)
Balance, March 31, 2021		220,712,124			3		4,085		(731	)		(38	)		1,603			(1,359	)		171			3,734
Net income		—			—		—		—			—			156			—			16			172
Other comprehensive income		—			—		—		—			—			—			41			1			42
Vesting of stock awards		3,732			—		—		—			—			—			—			—			—
Recognition of stock-based compensation		—			—		2		—			4			—			—			—			6
Repurchase and cancellation of stock awards		(19,912	)		—		—		—			—			(1	)		—			—			(1	)
Stock options exercised		263,962			—		6		—			—			(3	)		—			—			3
Dividends declared to noncontrolling interests		—			—		—		—			—			—			—			(30	)		(30	)
Dividends declared on common stock ($0.1875 per share)		—			—		—		—			—			(41	)		—			—			(41	)
Balance, June 30, 2021		220,959,906			3		4,093		(731	)		(34	)		1,714			(1,318	)		158			3,885
Net income		—			—		—		—			—			209			—			16			225
Other comprehensive (loss) income		—			—		—		—			—			—			(20	)		1			(19	)
Issuance of nonvested stock awards		—			—		1		—			(1	)		—			—			—			—
Vesting of stock awards		7,695			—		—		—			—			—			—			—			—
Recognition of stock-based compensation		—			—		1		—			5			—			—			—			6
Repurchase and cancellation of stock awards		(1,869	)		—		—		—			—			—			—			—			—
Stock options exercised		34,372			—		1		—			—			—			—			—			1
Treasury stock repurchased		(3,971,784	)		—		—		(102	)		—			—			—			—			(102	)
Dividends declared on common stock ($0.1875 per share)		—			—		—		—			—			(42	)		—			—			(42	)
Balance, September 30, 2021		217,028,320		$	3	$	4,096	$	(833	)	$	(30	)	$	1,881		$	(1,338	)	$	175		$	3,954

~~As of March 31, 2022 and 2021, the amount of capital expenditures in accounts payable was $44 million and $54 million, respectively.~~

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

	*Nine months*
	*ended*
	*September 30,*
	*2022*			*2021*
Operating Activities:
Net income	$	597		$	497
Less: Income from discontinued operations, net of tax		(30	)		(36	)
Income from continuing operations		567			461
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates		(55	)		(118	)
Unrealized net losses on fair value adjustments to Venator investment		9			28
Cash received from return on investment in unconsolidated subsidiary		61			31
Depreciation and amortization		207			205
Noncash lease expense		47			42
Gain on disposal of businesses/assets		—			(28	)
Loss on early extinguishment of debt		—			27
Noncash restructuring and impairment charges		(1	)		14
Deferred income taxes		81			(22	)
Stock-based compensation		26			23
Other, net		(15	)		(6	)
Changes in operating assets and liabilities:
Accounts and notes receivable		(60	)		(335	)
Inventories		(128	)		(270	)
Other current assets		357			20
Other noncurrent assets		(14	)		(84	)
Accounts payable		(113	)		134
Accrued liabilities		(292	)		88
Other noncurrent liabilities		(82	)		(28	)
Net cash provided by operating activities from continuing operations		595			182
Net cash provided by (used in) operating activities from discontinued operations		9			(20	)
Net cash provided by operating activities		604			162

Investing Activities:
Capital expenditures		(186	)		(241	)
Cash received from sale of business		—			43
Acquisition of business, net of cash acquired		—			(245	)
Insurance proceeds for recovery of property damage		5			3
Other, net		5			10
Net cash used in investing activities from continuing operations		(176	)		(430	)
Net cash used in investing activities from discontinued operations		(12	)		(9	)
Net cash used in investing activities		(188	)		(439	)

Financing Activities:
Net borrowings on revolving loan facilities		—			8
Proceeds from issuance of long-term debt		—			427
Repayments of long-term debt		(8	)		(965	)
Debt issuance costs paid		—			(4	)
Dividends paid to noncontrolling interests		—			(30	)
Dividends paid to common stockholders		(132	)		(119	)
Repurchase and cancellation of awards		(14	)		(7	)
Repurchase of common stock		(755	)		(102	)
Proceeds from issuance of common stock		6			7
Costs of early extinguishment of debt		—			(26	)
Other, net		(2	)		2
Net cash used in financing activities		(905	)		(809	)
Effect of exchange rate changes on cash		(37	)		(2	)
Decrease in cash and cash equivalents		(526	)		(1,088	)
Cash and cash equivalents at beginning of period		1,041			1,593
Cash and cash equivalents at end of period	$	515		$	505

Supplemental cash flow information:
Cash paid for interest	$	41		$	57
Cash paid for income taxes		171			83

As of September 30, 2022 and 2021, the amount of capital expenditures in accounts payable was $27 million and $52 million, respectively. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based do-it-yourself (“DIY”) business was $3 million. See “Note 4. Discontinued Operations and Business Dispositions— Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Unit Amounts)

	*March 31,*			*December 31,*			*September 30,*			*December 31,*
	*2022*			*2021*			*2022*			*2021*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	806		$	1,039		$	515		$	1,039
Accounts and notes receivable (net of allowance for doubtful accounts of $23 and $25, respectively), ($372 and $324 pledged as collateral, respectively)(a)		1,285			1,159
Accounts and notes receivable (net of allowance for doubtful accounts of $11 and $12, respectively), ($348 and $324 pledged as collateral, respectively)(a)								981			988
Accounts receivable from affiliates		479			269			1,035			269
Inventories(a)		1,382			1,201			1,079			1,038
Receivable associated with the Albemarle Settlement		333			333			—			333
Other current assets		155			165			115			153
Current assets held for sale								483			346
Total current assets		4,440			4,166			4,208			4,166
Property, plant and equipment, net(a)		2,551			2,576			2,288			2,443
Investment in unconsolidated affiliates		485			470			430			470
Intangible assets, net		461			469			433			469
Goodwill		650			650			636			650
Deferred income taxes		204			206			167			180
Operating lease right-of-use assets		390			403			359			381
Other noncurrent assets(a)		673			691			623			690
Noncurrent assets held for sale								—			182
Total assets	$	9,854		$	9,631		$	9,144		$	9,631

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	1,242		$	1,145		$	865		$	1,051
Accounts payable to affiliates		65			62			40			62
Accrued liabilities(a)		723			771			386			704
Current portion of debt(a)		21			12			12			12
Current operating lease liabilities(a)		50			51			50			49
Current liabilities held for sale								242			163
Total current liabilities		2,101			2,041			1,595			2,041
Long-term debt(a)		1,529			1,538			1,476			1,538
Deferred income taxes		181			163			251			163
Noncurrent operating lease liabilities(a)		358			370			326			346
Other noncurrent liabilities(a)		671			700			494			573
Noncurrent liabilities held for sale								—			151
Total liabilities		4,840			4,812			4,142			4,812
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman International LLC members’ equity:
Members’ equity, 2,728 units issued and outstanding		3,741			3,732			3,756			3,732
Retained earnings		2,274			2,093			2,518			2,093
Accumulated other comprehensive loss		(1,198	)		(1,187	)		(1,482	)		(1,187	)
Total Huntsman International LLC members’ equity		4,817			4,638			4,792			4,638
Noncontrolling interests in subsidiaries		197			181			210			181
Total equity		5,014			4,819			5,002			4,819
Total liabilities and equity	$	9,854		$	9,631		$	9,144		$	9,631

(a)

See accompanying notes to condensed consolidated financial statements.

~~Table of Contents~~

~~HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES~~

~~CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS~~

~~(In Millions)~~

Three months

ended

March 31,

2022

2021

Revenues:

Trade sales, services and fees, net
$ 2,329 $ 1,802
Related party sales
60 35
Total revenues
2,389 1,837
Cost of goods sold
1,824 1,445
Gross profit
565 392
Operating expenses:

Selling, general and administrative
213 204
Research and development
38 38
Restructuring, impairment and plant closing costs
0 24
Other operating expenses (income), net
7 (3 )
Total operating expenses
258 263
Operating income
307 129
Interest expense, net
(14 ) (19 )
Equity in income of investment in unconsolidated affiliates
15 38
Fair value adjustments to Venator investment
(2 ) (19 )
Other income, net
1 7
Income from continuing operations before income taxes
307 136
Income tax expense
(65 ) (35 )
Income from continuing operations
242 101
Income from discontinued operations, net of tax
1 1
Net income
243 102
Net income attributable to noncontrolling interests
(17 ) (17 )
Net income attributable to Huntsman International LLC
$ 226 $ 85

~~See accompanying notes to condensed consolidated financial statements.~~

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~COMPREHENSIVE INCOME~~ OPERATIONS

(In Millions)

Three months

ended

March 31,

2022

2021

Net income
$ 243 $ 102
Other comprehensive loss, net of tax:

Foreign currency translations adjustment
(20 ) (31 )
Pension and other postretirement benefits adjustments
9 19
Other, net
(1 ) 0
Other comprehensive loss, net of tax
(12 ) (12 )
Comprehensive income
231 90
Comprehensive income attributable to noncontrolling interests
(16 ) (17 )
Comprehensive income attributable to Huntsman International LLC
$ 215 $ 73

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Revenues:
Trade sales, services and fees, net	$	1,946		$	2,042		$	6,189		$	5,418
Related party sales		65			55			184			140
Total revenues		2,011			2,097			6,373			5,558
Cost of goods sold		1,662			1,660			5,017			4,397
Gross profit		349			437			1,356			1,161
Operating expenses:
Selling, general and administrative		166			175			528			530
Research and development		31			35			97			102
Restructuring, impairment and plant closing costs (credits)		12			(1	)		36			34
Gain on sale of India-based DIY business		—			—			—			(28	)
Other operating expense (income), net		3			(3	)		(8	)		(13	)
Total operating expenses		212			206			653			625
Operating income		137			231			703			536
Interest expense, net		(16	)		(15	)		(46	)		(52	)
Equity in income of investment in unconsolidated affiliates		21			34			55			118
Fair value adjustments to Venator investment, net		(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt		—			—			—			(27	)
Other income, net		10			7			23			19
Income from continuing operations before income taxes		145			254			726			566
Income tax expense		(30	)		(35	)		(156	)		(102	)
Income from continuing operations		115			219			570			464
(Loss) income from discontinued operations, net of tax		(1	)		6			30			36
Net income		114			225			600			500
Net income attributable to noncontrolling interests		(15	)		(16	)		(46	)		(49	)
Net income attributable to Huntsman International LLC	$	99		$	209		$	554		$	451

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~EQUITY~~COMPREHENSIVE (LOSS) INCOME

(In ~~Millions, Except Unit Amounts)~~Millions)

Huntsman International LLC Members

Members'

Accumulated other

Noncontrolling

equity

comprehensive

interests in

Total

Units

Amount

Retained earnings

loss

subsidiaries

equity

Balance, January 1, 2022
2,728 $ 3,732 $ 2,093 $ (1,187 ) $ 181 $ 4,819
Net income
— 0 226 0 17 243
Dividends paid to parent
— 0 (45 ) 0 0 (45 )
Other comprehensive loss
— 0 0 (11 ) (1 ) (12 )
Contribution from parent
— 9 0 0 0 9
Balance, March 31, 2022
2,728 $ 3,741 $ 2,274 $ (1,198 ) $ 197 $ 5,014

Huntsman International LLC Members

Members'

Accumulated other

Noncontrolling

equity

comprehensive

interests in

Total

Units

Amount

Retained earnings

loss

subsidiaries

equity

Balance, January 1, 2021
2,728 $ 3,701 $ 1,203 $ (1,333 ) $ 154 $ 3,725
Net income
— 0 85 0 17 102
Dividends paid to parent
— 0 (36 ) 0 0 (36 )
Other comprehensive loss
— 0 0 (12 ) — (12 )
Contribution from parent
— 8 0 0 0 8
Balance, March 31, 2021
2,728 $ 3,709 $ 1,252 $ (1,345 ) $ 171 $ 3,787

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Net income	$	114		$	225		$	600		$	500
Other comprehensive (loss) income, net of tax:
Foreign currency translations adjustment		(204	)		(36	)		(339	)		(42	)
Pension and other postretirement benefits adjustments		10			17			28			53
Other, net		—			—			(1	)		—
Other comprehensive (loss) income, net of tax		(194	)		(19	)		(312	)		11
Comprehensive (loss) income		(80	)		206			288			511
Comprehensive loss (income) attributable to noncontrolling interests		(6	)		(17	)		(29	)		(51	)
Comprehensive (loss) income attributable to Huntsman International LLC	$	(86	)	$	189		$	259		$	460

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF ~~CASH FLOWS~~EQUITY

(In ~~Millions)~~Millions, Except Unit Amounts)

Three months

ended

March 31,

2022

2021

Operating Activities:

Net income
$ 243 $ 102
Less: Income from discontinued operations, net of tax
(1 ) (1 )
Income from continuing operations
242 101
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities from continuing operations:

Equity in income of investment in unconsolidated affiliates
(15 ) (38 )
Unrealized losses on fair value adjustments to Venator investment
2 19
Depreciation and amortization
71 73
Noncash lease expense
16 17
Noncash restructuring and impairment charges
0 8
Deferred income taxes
13 0
Noncash compensation
9 8
Other, net
3 1
Changes in operating assets and liabilities:

Accounts and notes receivable
(134 ) (117 )
Inventories
(187 ) (156 )
Other current assets
15 (3 )
Other noncurrent assets
(1 ) (30 )
Accounts payable
119 93
Accrued liabilities
(41 ) 14
Other noncurrent liabilities
(26 ) (7 )
Net cash provided by (used in) operating activities from continuing operations
86 (17 )
Net cash used in operating activities from discontinued operations
0 (1 )
Net cash provided by (used in) operating activities
86 (18 )

Investing Activities:

Capital expenditures
(69 ) (98 )
Acquisition of business, net of cash acquired
0 (240 )
Cash received from sale of business
0 15
Increase in receivable from affiliate
(212 ) (7 )
Other, net
3 0
Net cash used in investing activities
(278 ) (330 )

Financing Activities:

Net borrowings on revolving loan facilities
8 9
Repayments of long-term debt
(3 ) (548 )
Dividends paid to parent
(45 ) (36 )
Other, net
1 0
Net cash used in financing activities
(39 ) (575 )
Effect of exchange rate changes on cash
(2 ) (1 )
Decrease in cash and cash equivalents
(233 ) (924 )
Cash and cash equivalents at beginning of period
1,039 1,591
Cash and cash equivalents at end of period
$ 806 $ 667

Supplemental cash flow information:

Cash paid for interest
$ 9 $ 16
Cash paid for income taxes
32 8

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2022		2,728	$	3,732	$	2,093		$	(1,187	)	$	181		$	4,819
Net income		—		—		226			—			17			243
Dividends paid to parent		—		—		(45	)		—			—			(45	)
Other comprehensive loss		—		—		—			(11	)		(1	)		(12	)
Contribution from parent		—		9		—			—			—			9
Balance, March 31, 2022		2,728		3,741		2,274			(1,198	)		197			5,014
Net income		—		—		229			—			14			243
Dividends paid to parent		—		—		(42	)		—			—			(42	)
Other comprehensive loss		—		—		—			(99	)		(7	)		(106	)
Contribution from parent		—		10		—			—			—			10
Balance, June 30, 2022		2,728		3,751		2,461			(1,297	)		204			5,119
Net income		—		—		99			—			15			114
Dividends paid to parent		—		—		(42	)		—			—			(42	)
Other comprehensive loss		—		—		—			(185	)		(9	)		(194	)
Contribution from parent		—		5		—			—			—			5
Balance, September 30, 2022		2,728	$	3,756	$	2,518		$	(1,482	)	$	210		$	5,002

~~For March 31, 2022 and 2021, the amount of capital expenditures in accounts payable was $44 million and $54 million, respectively.~~

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*			*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2021		2,728	$	3,701	$	1,203		$	(1,333	)	$	154		$	3,725
Net income		—		—		85			—			17			102
Dividends paid to parent		—		—		(36	)		—			—			(36	)
Other comprehensive loss		—		—		—			(12	)		—			(12	)
Contribution from parent		—		8		—			—			—			8
Balance, March 31, 2021		2,728		3,709		1,252			(1,345	)		171			3,787
Net income		—		—		157			—			16			173
Dividends paid to parent		—		—		(41	)		—			—			(41	)
Other comprehensive income		—		—		—			41			1			42
Contribution from parent		—		7		—			—			—			7
Dividends declared to noncontrolling interests		—		—		—			—			(30	)		(30	)
Balance, June 30, 2021		2,728		3,716		1,368			(1,304	)		158			3,938
Net income		—		—		209			—			16			225
Dividends paid to parent		—		—		(41	)		—			—			(41	)
Other comprehensive loss		—		—		—			(20	)		1			(19	)
Contribution from parent		—		8		—			—			—			8
Balance, September 30, 2021		2,728	$	3,724	$	1,536		$	(1,324	)	$	175		$	4,111

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

	*Nine months*
	*ended*
	*September 30,*
	*2022*			*2021*
Operating Activities:
Net income	$	600		$	500
Less: Income from discontinued operations, net of tax		(30	)		(36	)
Income from continuing operations		570			464
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:
Equity in income of investment in unconsolidated affiliates		(55	)		(118	)
Unrealized net losses on fair value adjustments to Venator investment		9			28
Cash received from return on investment in unconsolidated subsidiary		61			31
Depreciation and amortization		207			205
Noncash lease expense		47			42
Gain on disposal of businesses/assets		—			(28	)
Loss on early extinguishment of debt		—			27
Noncash restructuring and impairment charges		(1	)		14
Deferred income taxes		81			(22	)
Noncash compensation		24			22
Other, net		(15	)		(8	)
Changes in operating assets and liabilities:
Accounts and notes receivable		(60	)		(335	)
Inventories		(128	)		(270	)
Other current assets		356			28
Other noncurrent assets		(14	)		(84	)
Accounts payable		(113	)		133
Accrued liabilities		(290	)		82
Other noncurrent liabilities		(82	)		(25	)
Net cash provided by operating activities from continuing operations		597			186
Net cash provided by (used in) operating activities from discontinued operations		9			(20	)
Net cash provided by operating activities		606			166

Investing Activities:
Capital expenditures		(186	)		(241	)
Cash received from sale of business		—			43
Acquisition of business, net of cash acquired		—			(245	)
Increase in receivable from affiliate		(766	)		(105	)
Insurance proceeds for recovery of property damage		5			3
Other, net		5			10
Net cash used in investing activities from continuing operations		(942	)		(535	)
Net cash used in investing activities from discontinued operations		(12	)		(9	)
Net cash used in investing activities		(954	)		(544	)

Financing Activities:
Net borrowings on revolving loan facilities		—			8
Proceeds from issuance of long-term debt		—			427
Repayments of long-term debt		(8	)		(965	)
Debt issuance costs paid		—			(4	)
Dividends paid to noncontrolling interests		—			(30	)
Dividends paid to parent		(129	)		(118	)
Costs of early extinguishment of debt		—			(26	)
Other, net		(2	)		2
Net cash used in financing activities		(139	)		(706	)
Effect of exchange rate changes on cash		(37	)		(2	)
Decrease in cash and cash equivalents		(524	)		(1,086	)
Cash and cash equivalents at beginning of period		1,039			1,591
Cash and cash equivalents at end of period	$	515		$	505

Supplemental cash flow information:
Cash paid for interest	$	41		$	57
Cash paid for income taxes		171			83

For September 30, 2022 and 2021, the amount of capital expenditures in accounts payable was $27 million and $52 million, respectively. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based DIY business was $3 million. See “Note 4. Discontinued Operations and Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

See accompanying notes to condensed consolidated financial statements.

Table of Contents

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. GENERAL

Certain Definitions

For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).

In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.

Interim Financial Statements

Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income, ~~(loss),~~ financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2021 for our Company and Huntsman International.

Description of Businesses

We are a global manufacturer of differentiated organic chemical products. We operate in 4three segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining and synthetic fiber ~~textile chemicals and dyes~~ industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer ~~formulations,~~formulations.

On August 9, 2022, we entered into a definitive agreement to sell our textile chemicals and ~~dyes.~~dyes business (“Textile Effects Business”) to Archroma, a portfolio company of SK Capital Partners (“Archroma”). Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.” An insignificant impact on earnings from businesses previously divested is also reported in discontinued operations.

We operate our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.

Huntsman Corporation and Huntsman International Financial Statements

Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our financial statements and Huntsman International’s financial statements relate primarily to different capital structures and purchase accounting recorded at our Company for the ~~following:~~2003 step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in 2005.

●

~~purchase accounting recorded at our Company for the~~ ~~2003~~ ~~step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in~~ ~~2005;~~ ~~and~~

●

~~the different capital structures.~~

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.

~~Table of Contents~~

R~~ecent~~ eclD~~evelopments~~assfications

~~Share Repurchase Program~~

On ~~March 25, 2022,~~ ~~our Board of Directors increased~~Certain amounts in the ~~authorization~~condensed consolidated financial statements for prior periods have been recast for all periods presented to conform with the current presentation. These reclassifications were to present the assets and liabilities of our ~~existing share repurchase program from $1 billion to $2 billion. Repurchases~~Textile Effects Business as held for sale and its results of operations as discontinued operations. See “— Recent Developments” below as well as “Note ~~may~~ 4.~~be made through the open market or in privately negotiated transactions,~~ Discontinued Operations and ~~repurchases~~ ~~may~~ ~~be commenced or suspended from time to time without prior notice. Shares~~Business Dispositions—Sale of ~~common stock acquired through the repurchase program are held in treasury at cost.~~

~~Dividend Increase~~

On ~~February 14, 2022,~~ ~~our Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend.~~

Textile Effects Business.”

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Table of Contents

Recent Developments

European Restructuring Program

In early November 2022, we announced our commitment and specific plans to further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we expect to record restructuring expenses of approximately $50 million through 2023.

Sale of Textile Effects Business

On August 9, 2022, we entered into a definitive agreement to sell our Textile Effects Business to Archroma for a total enterprise value of $718 million, which includes the assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. We anticipate the transaction will close no later than the first half of 2023. Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.”

2. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

There have been no recently issued accounting pronouncements during the ~~three~~nine months ended ~~March 31,~~September 30, 2022that are applicable to us.

3. BUSINESS COMBINATIONS

Acquisition of gaBRIEL Performance Products

On January 15, 2021, we completed the acquisition of Gabriel Performance Products, a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets ~~(“Gabriel~~(the “Gabriel Acquisition”), from funds affiliated with Audax Private Equity in an all-cash transaction of approximately $251 ~~million, subject to customary closing adjustments.~~million. The purchase price was funded from available liquidity, and the acquired business ~~is being~~has been integrated into our Advanced Materials segment. Transaction costs related to this acquisition were approximately $1$2 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and were recorded in other operating income, net in our condensed consolidated statements of operations.

We accounted for the Gabriel Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

Fair value of assets acquired and liabilities assumed:
Cash paid for the Gabriel Acquisition	$	251

Cash	$	9
Accounts receivable		13
Inventories		23
Property, plant and equipment		50
Intangible assets		96
Goodwill		87
Accounts payable		(7	)
Accrued liabilities		(3	)
Deferred income taxes		(17	)
Total fair value of net assets acquired	$	251

The valuation was finalized during the first quarter of 2022. Intangible assets acquired included in this allocation consist of trademarks, technology and trade secrets, which are being amortized over a period of 15 years. The goodwill recognized is attributable primarily to projected future profitable growth in our Advanced Materials specialty portfolio and synergies. We acquired approximately $94 million of goodwill that will be deductible for income tax purposes.

1516

Table of Contents

PRO FORMA INFORMATION FOR ACQUISITION

If the Gabriel Acquisition were to have occurred on January 1, 2021, the following estimated pro forma revenues from continuing operations, net income and net income attributable to Huntsman Corporation and Huntsman International would have been reported (dollars in millions):

Three months

ended

March 31,

2021
Revenues
$ 1,841
Net income
88
Net income attributable to Huntsman Corporation
71

	*Nine months*
	*ended*
	*September 30, 2021*
Revenues	$	5,562
Net income		485
Net income attributable to Huntsman Corporation		436

	*Three months*
	*ended*		*Nine months*
	*March 31,*		*ended*
	*2021*		*September 30, 2021*
Revenues	$	1,841	$	5,562
Net income		90		488
Net income attributable to Huntsman International		73		439

4. DISCONTINUED OPERATIONS AND BUSINESS DISPOSITIONS 

SaLEof tEXTILE eFFECTS bUSINESS

The following table reconciles the carrying amounts of major classes of assets and liabilities of discontinued operations to total assets and liabilities of discontinued operations that are classified as held for sale in our condensed consolidated balance sheets (dollars in millions):

	*September 30,*		*December 31,*
	*2022*		*2021*
Carrying amounts of major classes of assets held for sale:
Accounts receivable	$	138	$	171
Inventories		173		163
Other current assets		12		12
Total current assets				346
Property, plant and equipment, net		120		133
Deferred income taxes		20		26
Operating lease right-of-use assets		16		22
Other noncurrent assets		4		1
Total noncurrent assets				182
Total assets held for sale(1)	$	483	$	528
Carrying amounts of major classes of liabilities held for sale:
Accounts payable	$	75	$	94
Accrued liabilities		43		67
Current operating lease liabilities		2		2
Total current liabilities				163
Noncurrent operating lease liabilities		17		24
Other noncurrent liabilities		105		127
Total noncurrent liabilities				151
Total liabilities held for sale(1)	$	242	$	314

(1)	Total assets and liabilities held for sale as of September 30, 2022 are classified as current because it is probable that the sale of our Textile Effects Business will close within a year.

Table of Contents

The following table reconciles major line items constituting pretax income of discontinued operations to after-tax income of discontinued operations, primarily related to our Textile Effects Business, as presented in our condensed consolidated statements of operations (dollars in millions):

	*Three months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Major line items constituting pretax income of discontinued operations:
Trade sales, services and fees, net	$	158		$	188		$	547		$	588
Cost of goods sold		127			142			420			443
Other expense items, net		25			31			83			91
Income from discontinued operations before income taxes		6			15			44			54
Income tax expense		(7	)		(9	)		(14	)		(18	)
Net (loss) income attributable to discontinued operations	$	(1	)	$	6		$	30		$	36

SALE OF INDIA-BASED DO-IT-YOURSELF CONSUMER ADHESIVES BUSINESS

On November 3, 2020, we completed the sale of the India-based DIY business to Pidilite Industries Ltd. and received cash of approximately $257 million. In the second quarter of 2021, we received the full payment of $28 million pursuant to an earnout provision based on the DIY business’s achievement of certain sales revenue targets in line with its 2019 performance. As a result, we recognized an additional pretax gain of $28 million in the second quarter of 2021, which was recorded in gain on sale of India-based DIY business in our condensed consolidated statements of operations.

SaLE of Venator InterEST

On December 23, 2020, we completed the sale of approximately 42.4 million ordinary shares of Venator Materials PLC (“Venator”). ~~Concurrently~~Concurrent with the sale of ordinary shares, we entered into an option agreement, pursuant to which we granted an option to funds advised by SK Capital Partners, LP to purchase the remaining approximate 9.7 million ordinary shares we hold in Venator at $2.15 per share. The option will expire on June 23, 2023 and will not be exercisable so long as such exercise would result in a default or an “Event of Default” under Venator’s Term Loan Credit Agreement and Revolving Credit Agreement. We record this option at fair value with changes in fair value reported in earnings. We account for our remaining ownership interest in Venator as an investment in equity securities that are marked to fair value with changes in fair value reported in earnings. For the three months ended ~~March 31,~~September 30, 2022 and 2021, we recorded net losses of $2$7 million and ~~$19~~$3 million, respectively, and for the nine months ended September 30, 2022 and 2021, we recorded net losses of $9 million and $28 million, respectively, to record our investment in Venator and related option at fair value. These net losses were recorded in “Fair value adjustments to Venator ~~investment”~~investment, net” in our condensed consolidated statements of operations.

5. INVENTORIES

We state our inventories at the lower of cost or market, with cost determined using average cost, last-in first-out (“LIFO”), and first-in first-out ~~and average cost~~ methods for different components of inventory. Inventories consisted of the following (dollars in millions):

	*March 31,*			*December 31,*			*September 30,*			*December 31,*
	*2022*			*2021*			*2022*			*2021*
Raw materials and supplies	$	332		$	282		$	263		$	248
Work in progress		66			52			44			33
Finished goods		1,029			909			822			799
Total		1,427			1,243			1,129			1,080
LIFO reserves		(45	)		(42	)		(50	)		(42	)
Net inventories	$	1,382		$	1,201		$	1,079		$	1,038

~~As of~~For both ~~March 31,~~September 30, 2022 and December 31, 2021, approximately 7%8% of inventories were recorded using the LIFO cost method.

1618

Table of Contents

6. VARIABLE INTEREST ENTITIES

We evaluate our investments and transactions to identify variable interest entities for which we are the primary beneficiary. We hold a variable interest in the following joint ventures for which we are the primary beneficiary:

●

Rubicon LLC is our 50%-owned joint venture with Lanxess that manufactures products for our Polyurethanes and Performance Products segments.

●

Arabian Amines Company (“AAC”) is our 50%-owned joint venture with Zamil group that manufactures products for our Performance Products segment.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, there were no changes in our variable interest entities.

Creditors of these entities have no recourse to our general credit. See “Note 8. Debt—Direct and Subsidiary Debt.” As the primary beneficiary of these variable interest entities at ~~March 31,~~September 30, 2022, the joint ventures’ assets, liabilities and results of operations are included in our condensed consolidated financial statements.

The following table summarizes the carrying amounts of our variable interest entities’ assets and liabilities included in our condensed consolidated balance sheet as of ~~March 31,~~September 30, 2022 and our consolidated balance sheet as of December 31, 2021 (dollars in millions):

	*March 31,*		*December 31,*		*September 30,*		*December 31,*
	*2022*		*2021*		*2022*		*2021*
Current assets	$	92	$	81	$	92	$	81
Property, plant and equipment, net		156		161		161		161
Operating lease right-of-use assets		25		26		30		26
Other noncurrent assets		147		148		138		148
Deferred income taxes		21		21		21		21
Total assets	$	441	$	437	$	442	$	437
Current liabilities	$	177	$	176	$	157	$	176
Long-term debt		33		35		28		35
Noncurrent operating lease liabilities		19		20		21		20
Other noncurrent liabilities		46		46		45		46
Total liabilities	$	275	$	277	$	251	$	277

The revenues, income from continuing operations before income taxes and net cash provided by operating activities for our variable interest entities for the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021 are as follows (dollars in millions):

	*Three months*				*Three months*				*Nine months*
	*ended*				*ended*				*ended*
	*March 31,*				*September 30,*				*September 30,*
	*2022*		*2021*		*2022*		*2021*		*2022*		*2021*
Revenues	$	0	$	0	$	—	$	—	$	—	$	—
Income from continuing operations before income taxes		5		0		11		4		24		11
Net cash provided by operating activities		8		4		21		6		56		14

1719

Table of Contents

7. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS

As of ~~March 31,~~September 30, 2022 and December 31, 2021, accrued restructuring costs by type of cost and initiative consisted of the following (dollars in millions):

	*Workforce reductions*			*Non-cancelable lease and contract termination costs*		*Other restructuring costs*			*Total*			*Workforce reductions*			*Other restructuring costs*			*Total*
Accrued liabilities as of January 1, 2022	$	28		$	2	$	1		$	31		$	25		$	1		$	26
2022 charges for 2022 and prior initiatives		0			0		0			0
2022 charges for 2021 and prior initiatives													17			6			23
2022 charges for 2022 initiatives													14			—			14
2022 payments for 2021 and prior initiatives		(6	)		0		(1	)		(7	)		(11	)		(6	)		(17	)
Accrued liabilities as of March 31, 2022	$	22		$	2	$	0		$	24
2022 payments for 2022 initiatives													(3	)		(1	)		(4	)
Accrued liabilities as of September 30, 2022												$	42		$	—		$	42

Details with respect to our reserves for restructuring, impairment and plant closing costs by segment and initiative are provided below (dollars in millions):

				*Performance*		*Advanced*			*Textile*			*Corporate*									*Performance*			*Advanced*			*Corporate*
	*Polyurethanes*			*Products*		*Materials*			*Effects*			*and Other*			*Total*			*Polyurethanes*			*Products*			*Materials*			*and other*			*Total*
Accrued liabilities as of January 1, 2022	$	9		$	1	$	5		$	5		$	11		$	31		$	9		$	1		$	5		$	11		$	26
2022 charges for 2022 and prior initiatives		0			0		0			0			0			0
2022 charges for 2021 and prior initiatives																			7			—			1			15			23
2022 charges for 2022 initiatives																			—			1			1			12			14
2022 payments for 2021 and prior initiatives		(3	)		0		(1	)		(1	)		(2	)		(7	)		(7	)		(1	)		(1	)		(8	)		(17	)
Accrued liabilities as of March 31, 2022	$	6		$	1	$	4		$	4		$	9		$	24
2022 payments for 2022 initiatives																			—			—			—			(4	)		(4	)
Accrued liabilities as of September 30, 2022																		$	9		$	1		$	6		$	26		$	42

Current portion of restructuring reserves	$	6		$	1	$	1		$	1		$	3		$	12		$	9		$	1		$	6		$	23		$	39
Long-term portion of restructuring reserves		0			0		3			3			6			12			—			—			—			3			3

Details with respect to cash and noncash restructuring charges from continuing operations for the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021 are provided below (dollars in millions):

	*Three months*				*Three months*						*Nine Months*
	*ended*				*ended*						*ended*
	*March 31,*				*September 30,*						*September 30,*
	*2022*		*2021*		*2022*			*2021*			*2022*			*2021*
Cash charges:
2022 charges for 2022 and prior initiatives	$	0	$	0
2022 (credits) charges for 2021 and prior initiatives					$	(1	)	$	—		$	23		$	—
2022 charges for 2022 initiatives						14			—			14			—
2021 charges for 2020 and prior initiatives		—		14		—			—			—			18
2021 charges for 2021 initiatives		0		2		—			—			—			2
Noncash charges:
Other noncash charges		0		8
Total restructuring, impairment and plant closing costs	$	0	$	24
Gain on sale of assets						(2	)		(3	)		(2	)		(3	)
Accelerated depreciation						—			4			—			11
Other noncash charges (credits)						1			(2	)		1			6
Total restructuring, impairment and plant closing costs (credits)					$	12		$	(1	)	$	36		$	34

Table of Contents

Restructuring Activities

Beginning in the third quarter of 2022, our Corporate function implemented restructuring programs to optimize our global approaches to leveraging managed services in various information technology functions and to align and optimize our environmental, health and safety processes and systems. In connection with these restructuring programs, we recorded net restructuring expense of approximately $12 million in the three months ended September 30, 2022, primarily related to workforce reductions. We expect to record further restructuring expenses of approximately $8 million through 2023.

Beginning in the first quarter of 2021, our Corporate ~~and other segment incurred restructuring costs related to~~function implemented a restructuring program to optimize our global approach to leveraging shared services capabilities. During the second quarter of 2022, this program was further expanded to include additional geographies. In connection with this restructuring program, we recorded net restructuring expense of approximately ~~$14~~$15 million and $16 million in the ~~three~~nine months ended ~~March 31,~~ September 30, 2022 and 2021, respectively, primarily related to workforce reductions. ~~There were 0 significant restructuring costs incurred during the~~ ~~three~~ ~~months ended~~ ~~March 31, 2022.~~ We expect to record further restructuring expenses of approximately $2$5 million through 2023.

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. During the second quarter of 2022, this optimization program was further expanded to include the entire Polyurethanes business. In connection with this restructuring program, we recorded net restructuring expense of approximately $1$7 million and $4 million in the ~~three~~nine months ended ~~March 31, 2021.~~ ~~There were 0 significant restructuring costs incurred during the~~ ~~three~~September 30, 2022 ~~months ended~~and ~~March 31, 2022.~~ 2021, respectively, primarily related to workforce reductions. We expect to record further restructuring expenses of ~~between~~ approximately $1 ~~million and~~ $2$9 million through the ~~first~~ ~~half~~end of ~~2022.~~2023.

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with the CVC Thermoset Specialties Acquisition, the alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. ~~There were 0 significant~~In connection with these restructuring ~~costs incurred during both~~programs, we recorded net restructuring expense of approximately $1 million and $8 million in the ~~three~~nine months ended ~~March 31,~~September 30, 2022and ~~2021.~~2021, respectively, primarily related to accelerated depreciation. We expect to record further restructuring expenses of approximately $6$9 million through the end of 2023.

~~Table of Contents~~

8. DEBT

Our outstanding debt, net of debt issuance costs, consisted of the following (dollars in millions):

	*March 31,*		*December 31,*		*September 30,*		*December 31,*
	*2022*		*2021*		*2022*		*2021*
Senior Credit Facilities:
Revolving facility	$	0	$	0	$	—	$	—
Amounts outstanding under A/R programs		0		0		—		—
Senior notes		1,468		1,473		1,423		1,473
Variable interest entities		50		45		38		45
Other		32		32		27		32
Total debt	$	1,550	$	1,550	$	1,488	$	1,550
Current portion of debt	$	21	$	12	$	12	$	12
Long-term portion of debt		1,529		1,538		1,476		1,538
Total debt	$	1,550	$	1,550	$	1,488	$	1,550

Direct and Subsidiary Debt

Substantially all of our debt, including the facilities described below, has been incurred by our subsidiaries (primarily Huntsman International). Huntsman Corporation is not a guarantor of such subsidiary debt.

Certain of our subsidiaries have third-party debt agreements that contain certain restrictions with regard to dividends, distributions, loans or advances. In certain circumstances, the consent of a third party would be required prior to the transfer of any cash or assets from these subsidiaries to us.

Debt Issuance Costs

We record debt issuance costs related to a debt liability on the balance sheets as a reduction to the face amount of that debt liability. As of ~~March 31,~~September 30, 2022 and December 31, 2021, the amount of debt issuance costs directly reducing the debt liability was $9$8 million and $10 million, respectively. We ~~record the amortization of~~amortize debt issuance costs using either a straight line or effective interest method, depending on the debt agreement, and record them as interest expense.

Table of Contents

Revolving Credit Facility

~~As of~~On ~~March 31,~~May 20, 2022,~~, our~~Huntsman International entered into a new $1.2 billion senior unsecured revolving credit facility (“(the “2022Revolving Credit Facility”) ~~was~~. Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Revolving Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions. In connection with entering into the 2022 Revolving Credit Facility, Huntsman International terminated all commitments and repaid all obligations under its 2018 $1.2 billion senior unsecured credit facility.

The following table presents certain amounts under our 2022 Revolving Credit Facility as ~~follows~~of September 30, 2022 (monetary amounts in millions):

Unamortized

discounts and

Committed

Principal

debt issuance

Carrying

Committed

Principal

debt issuance

Carrying

Facility

amount

outstanding

costs

value

Interest rate(2)

Maturity

amount

outstanding

costs

value

Interest rate(2)

Maturity

Revolving Credit Facility

1,200

(1)

USD LIBOR plus 1.50%

2023

2022 Revolving Credit Facility

1,200

—

(1)

—

(1)

—

(1)

Term Secured Overnight Financing Rate (“SOFR”) plus 1.475%

May 2027

(1)	On ~~March 31,~~September 30, 2022, we had an additional $3$11 million (U.S. dollar equivalents) of letters of credit and bank guarantees issued and outstanding under our2022 Revolving Credit Facility.

(2)	Interest rates on borrowings under the 2022Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The representative interest rate for U.S. dollar borrowings as of ~~March 31,~~September 30, 2022 was ~~1.50%~~1.475% above ~~LIBOR.~~term SOFR.

~~Table of Contents~~

A/R Programs

Our U.S. accounts receivable securitization program (“U.S. A/R Programs”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”) are structured so that we transfer certain of our trade receivables to the U.S. special purpose entity (“U.S. SPE”) and the European special purpose entity (“EU SPE”) in transactions intended to be true sales or true contributions. The receivables collateralize debt incurred by the U.S. SPE and the EU SPE.

On July 1, 2021, we entered into amendments to our A/R Programs that, among other things, extended the respective scheduled termination dates of our A/R Programs from April 2022 to July 2024.

Information regarding our A/R Programs as of ~~March 31,~~September 30, 2022 was as follows (monetary amounts in millions):

Maximum funding

Amount

Maximum funding

Amount

Facility

Maturity

availability(1)

outstanding

Interest rate⁽²⁾

Maturity

availability(1)

outstanding

Interest rate(2)

U.S. A/R Program

July 2024

150

(3)

Applicable rate plus 0.90%

July 2024

150

—

(3)

Applicable rate plus 0.90%

EU A/R Program

July 2024

€

100

€

Applicable rate plus 1.30%

July 2024

€

100

€

—

Applicable rate plus 1.30%

(or approximately $111)

(or approximately $96)

(1)

The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements.

(2)

The applicable rate for our U.S. A/R Program is defined by the lender as USD LIBOR. The applicable rate for our EU A/R Program is either USD LIBOR, EURIBOR or SONIA (Sterling Overnight Interbank Average Rate). In anticipation of the transition away from USD LIBOR, the amendments we made in July 2021 to our A/R Programs incorporated replacement rates for the USD LIBOR.

(3)	As of ~~March 31,~~September 30, 2022, we had approximately $8 million (U.S. dollar equivalents) of letters of credit issued and outstanding under our U.S. A/R Program.

As of ~~March 31,~~September 30, 2022 and December 31, 2021, ~~$372~~$348 million and $324 million, respectively, of accounts receivable were pledged as collateral under our A/R Programs.

Senior Notes

On January 15, 2021, Huntsman International redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 5.125% senior notes due 2021 (“2021 Senior Notes”) at the redemption price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest to, but not including, the redemption date. In connection with this redemption, we incurred an incremental cash tax liability of approximately $15 million in the first quarter of 2021 related to foreign currency exchange gains.

On May 26, 2021, Huntsman International completed a $400 million offering of its 2.95% senior notes due 2031 (“2031 Senior Notes”). On June 23, 2021, Huntsman International applied the net proceeds from the offering, along with cash on hand, to redeem in full $400 million in aggregate principal amount of its 5.125% senior notes due 2022 (“2022 Senior Notes”) and to pay accrued but unpaid interest of approximately $2 million. In addition, we paid redemption premiums and related fees and expenses of approximately $25 million and recognized a corresponding loss on early extinguishment of debt of $26 million in the second quarter of 2021.

Table of Contents

Variable Interest Entity Debt

On September 30, 2021, AAC, our consolidated 50%-owned joint venture, entered into a new term loan facility of 177 million Saudi riyal (“SAR”) (approximately $47 million) with Saudi British Bank, of which approximately 104 million SAR (approximately $27 million) was funded with the remainder being funded subsequent to September 30, 2021. A portion of these funds were used to repay existing debt subsequent to September 30, 2021. As of ~~March 31,~~September 30, 2022, AAC, our consolidated 50%-owned joint venture, had ~~$50~~$38 million outstanding under its loan commitments and debt financing arrangements. As of ~~March 31,~~September 30, 2022, we have ~~$17~~$10 million classified as current debt and ~~$33~~$28 million as long-term debt on our condensed consolidated balance sheets. We do not guarantee these loan commitments, and AAC is not a guarantor of any of our other debt obligations.

Compliance with Covenants

We believe that we are in compliance with the covenants contained in the agreements governing our material debt instruments, including our Revolving Credit Facility, our A/R Programs and our senior notes.

~~Table of Contents~~

9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations.

Our revenues and expenses are denominated in various foreign currencies, and our cash flows and earnings are thus subject to fluctuations due to exchange rate variations. From time to time, we may enter into foreign currency derivative instruments to minimize the short-term impact of movements in foreign currency rates. Where practicable, we generally net multicurrency cash balances among our subsidiaries to help reduce exposure to foreign currency exchange rates. Certain other exposures may be managed from time to time through financial market transactions, principally through the purchase of spot or forward foreign exchange contracts (generally with maturities of one year or less). We do not hedge our foreign currency exposures in a manner that would eliminate the effect of changes in exchange rates on our cash flows and earnings. As of ~~March 31,~~September 30, 2022, we had approximately ~~$157~~$225 million in notional amount (in U.S. dollar equivalents) outstanding in forward foreign currency ~~contracts.~~contracts related to continuing operations.

From time to time, we may purchase interest rate swaps and/or other derivative instruments to reduce the impact of changes in interest rates on our floating-rate exposures. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount.

We review our non-U.S. dollar denominated debt and derivative instruments to determine the appropriate amounts designated as hedges. As of ~~March 31,~~September 30, 2022, we have designated approximately €~~130~~175 million (approximately ~~$144~~$168 million) of euro-denominated debt as a hedge of our net investment. For the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and ~~March 31,~~ 2021,, the ~~amount~~amounts recognized on the hedge of our net investment were ~~gains~~a loss of $3$29 million and $8a gain of $7 million, respectively, and were recorded in other comprehensive (loss) income in our condensed consolidated statements of comprehensive income.

10. FAIR VALUE

The fair values of financial instruments were as follows (dollars in millions):

	*March 31, 2022*						*December 31, 2021*						*September 30, 2022*						*December 31, 2021*
	*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*
	*value*			*fair value*			*value*			*fair value*			*value*			*fair value*			*value*			*fair value*
Non-qualified employee benefit plan investments	$	20		$	20		$	25		$	25		$	15		$	15		$	25		$	25
Investment in Venator		17			17			25			25			9			9			25			25
Option agreement for remaining Venator shares		(2	)		(2	)		(7	)		(7	)		—			—			(7	)		(7	)
Long-term debt (including current portion)		(1,550	)		(1,579	)		(1,550	)		(1,698	)		(1,488	)		(1,304	)		(1,550	)		(1,698	)

The carrying amounts reported in the balance sheets of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. Our investment in Venator is marked to fair value, which is obtained through market observable pricing using prevailing market prices (Level 1). Additionally, the estimated fair value of the option agreement related to the remaining ordinary shares we hold in Venator, which rounds to nil as of September 30, 2022, is based on a valuation technique using market observable inputs (Level 2). See “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest.” The fair values of non-qualified employee benefit plan investments are obtained through market observable pricing using prevailing market prices (Level 1). The estimated fair values of our long-term debt are based on quoted market prices for the identical liability when traded in an active market (Level 1). The fair value estimates presented herein are based on pertinent information available to management as of ~~March 31,~~September 30, 2022 and December 31, 2021. Although we are not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since ~~March 31,~~September 30, 2022, and current estimates of fair value may differ significantly from the amounts presented herein.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, we held 0no instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3), and there were 0no gains or losses (realized and unrealized) included in our earnings for instruments categorized as Level 3 within the fair value hierarchy.

2123

Table of Contents

11. REVENUE RECOGNITION

The following tables disaggregate our revenue from continuing operations by major source for the three months ended ~~March 31,~~September 30, 2022 and 2021 (dollars in millions):

			*Performance*		*Advanced*		*Textile*		*Corporate and*								*Performance*		*Advanced*		*Corporate and*
2022	*Polyurethanes*		*Products*		*Materials*		*Effects*		*eliminations*			*Total*			*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	560	$	205	$	106	$	15	$	(3	)	$	883		$	547	$	216	$	104	$	(3	)	$	864
Europe		355		120		128		32		(4	)		631			280		90		114		(3	)		481
Asia Pacific		360		124		71		119		(1	)		673			335		97		82		(1	)		513
Rest of world		111		31		30		31		(1	)		202			95		31		28		(1	)		153
	$	1,386	$	480	$	335	$	197	$	(9	)	$	2,389		$	1,257	$	434	$	328	$	(8	)	$	2,011

Major product groupings
MDI urethanes	$	1,386										$	1,386		$	1,257								$	1,257
Differentiated			$	480									480				$	434							434
Specialty					$	306							306						$	306					306
Non-specialty						29							29							22					22
Textile chemicals and dyes							$	197					197
Eliminations									$	(9	)		(9	)							$	(8	)		(8	)
	$	1,386	$	480	$	335	$	197	$	(9	)	$	2,389		$	1,257	$	434	$	328	$	(8	)	$	2,011

Performance

Advanced

Textile

Corporate and

2021

Polyurethanes

Products

Materials

Effects

eliminations

Total

Primary geographic markets(1)

U.S. and Canada
$ 371 $ 120 $ 83 $ 13 $ (3 ) $ 584
Europe
279 77 99 31 (3 ) 483
Asia Pacific
336 91 71 119 0 617
Rest of world
82 17 25 30 (1 ) 153
$ 1,068 $ 305 $ 278 $ 193 $ (7 ) $ 1,837

Major product groupings

MDI urethanes
$ 1,068 $ 1,068
Differentiated
$ 305 305
Specialty
$ 245 245
Non-specialty
33 33
Textile chemicals and dyes
$ 193 193
Eliminations
$ (7 ) (7 )
$ 1,068 $ 305 $ 278 $ 193 $ (7 ) $ 1,837

			Performance		Advanced		Corporate and
2021	Polyurethanes		Products		Materials		eliminations			Total
Primary geographic markets(1)
U.S. and Canada	$	537	$	183	$	90	$	(6	)	$	804
Europe		377		106		108		(3	)		588
Asia Pacific		379		88		78		(1	)		544
Rest of world		110		22		28		1			161
	$	1,403	$	399	$	304	$	(9	)	$	2,097

Major product groupings
MDI urethanes	$	1,403								$	1,403
Differentiated			$	399							399
Specialty					$	276					276
Non-specialty						28					28
Eliminations							$	(9	)		(9	)
	$	1,403	$	399	$	304	$	(9	)	$	2,097

(1)	Geographic information for revenues is based upon countries into which product is sold.

2224

Table of Contents

The following tables disaggregate our revenue from continuing operations by major source for the nine months ended September 30, 2022 and 2021 (dollars in millions):

			*Performance*		*Advanced*		*Corporate and*
2022	*Polyurethanes*		*Products*		*Materials*		*eliminations*			*Total*
Primary geographic markets(1)
U.S. and Canada	$	1,678	$	644	$	320	$	(10	)	$	2,632
Europe		983		327		365		(11	)		1,664
Asia Pacific		1,027		341		227		(4	)		1,591
Rest of world		308		94		87		(3	)		486
	$	3,996	$	1,406	$	999	$	(28	)	$	6,373

Major product groupings
MDI urethanes	$	3,996								$	3,996
Differentiated			$	1,406							1,406
Specialty					$	921					921
Non-specialty						78					78
Eliminations							$	(28	)		(28	)
	$	3,996	$	1,406	$	999	$	(28	)	$	6,373

			Performance		Advanced		Corporate and
2021	Polyurethanes		Products		Materials		eliminations			Total
Primary geographic markets(1)
U.S. and Canada	$	1,338	$	460	$	262	$	(15	)	$	2,045
Europe		949		283		317		(8	)		1,541
Asia Pacific		1,055		276		223		(1	)		1,553
Rest of world		284		56		79		—			419
	$	3,626	$	1,075	$	881	$	(24	)	$	5,558

Major product groupings
MDI urethanes	$	3,626								$	3,626
Differentiated			$	1,075							1,075
Specialty					$	795					795
Non-specialty						86					86
Eliminations							$	(24	)		(24	)
	$	3,626	$	1,075	$	881	$	(24	)	$	5,558

(1)	Geographic information for revenues is based upon countries into which product is sold.

Table of Contents

12. EMPLOYEE BENEFIT PLANS

Components of the net periodic benefit ~~costs~~(credit) cost from continuing operations for the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021 were as follows (dollars in millions):

Huntsman Corporation

							*Other postretirement*												*Other postretirement*
	*Defined benefit plans*						*benefit plans*						*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*						*Three months*						*Three months*
	*ended*						*ended*						*ended*						*ended*
	*March 31,*						*March 31,*						*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*			*2022*			*2021*			*2022*			*2021*
Service cost	$	12		$	14		$	0		$	0		$	11		$	12		$	1		$	1
Interest cost		14			12			0			0			13			13			—			—
Expected return on assets		(42	)		(42	)		0			0			(37	)		(39	)		—			—
Amortization of prior service benefit		(1	)		(2	)		(1	)		(1	)		(2	)		(2	)		(1	)		(1	)
Amortization of actuarial loss		14			23			1			1			12			20			—			—
Settlement loss		0			3			0			0
Net periodic benefit cost	$	(3	)	$	8		$	0		$	0
Net periodic benefit (credit) cost													$	(3	)	$	4		$	—		$	—

							*Other postretirement*
	*Defined benefit plans*						*benefit plans*
	*Nine months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Service cost	$	34		$	38		$	1		$	1
Interest cost		41			36			1			1
Expected return on assets		(113	)		(115	)		—			—
Amortization of prior service benefit		(4	)		(4	)		(3	)		(3	)
Amortization of actuarial loss		36			60			1			1
Settlement loss		—			3			—			—
Net periodic benefit (credit) cost	$	(6	)	$	18		$	—		$	—

Huntsman International

							*Other postretirement*												*Other postretirement*
	*Defined benefit plans*						*benefit plans*						*Defined benefit plans*						*benefit plans*
	*Three months*						*Three months*						*Three months*						*Three months*
	*ended*						*ended*						*ended*						*ended*
	*March 31,*						*March 31,*						*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*			*2022*			*2021*			*2022*			*2021*
Service cost	$	12		$	14		$	0		$	0		$	11		$	12		$	1		$	1
Interest cost		14			12			0			0			13			13			—			—
Expected return on assets		(42	)		(42	)		0			0			(37	)		(39	)		—			—
Amortization of prior service benefit		(1	)		(2	)		(1	)		(1	)		(2	)		(2	)		(1	)		(1	)
Amortization of actuarial loss		14			24			1			1			12			21			—			—
Settlement loss		0			3			0			0
Net periodic benefit cost	$	(3	)	$	9		$	0		$	0
Net periodic benefit (credit) cost													$	(3	)	$	5		$	—		$	—

							*Other postretirement*
	*Defined benefit plans*						*benefit plans*
	*Nine months*						*Nine months*
	*ended*						*ended*
	*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*
Service cost	$	34		$	38		$	1		$	1
Interest cost		41			36			1			1
Expected return on assets		(113	)		(115	)		—			—
Amortization of prior service benefit		(4	)		(4	)		(3	)		(3	)
Amortization of actuarial loss		36			62			1			1
Settlement loss		—			3			—			—
Net periodic benefit (credit) cost	$	(6	)	$	20		$	—		$	—

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, we made contributions to our pension and other postretirement benefit plans related to continuing operations of ~~$13~~$35 million and ~~$14~~$41 million, respectively. During the remainder of 2022, we expect to contribute an additional amount of approximately ~~$36~~$10 million to these plans.

2326

Table of Contents

13. HUNTSMAN CORPORATION STOCKHOLDERS’ EQUITY

Share Repurchase Program

On October 26, 2021, our Board of Directors approved a new share repurchase program of $1 billion. In conjunction with the inception of this plan, we retired our prior share repurchase program. On March 25, 2022, our Board of Directors increased the authorization of our existing share repurchase program from $1 billion to $2 billion. During the ~~first~~nine ~~quarter of~~months ended September 30, 2022, we repurchased ~~5,549,348~~22,853,686 shares of our common stock for approximately ~~$210~~$752 million, excluding commissions, under this share repurchase program. From ~~April~~October 1, 2022 through ~~April 20,~~October 25, 2022, we repurchased an additional ~~906,000~~1,539,537 shares of our common stock for approximately ~~$32~~$40 million, excluding commissions.

Dividends on Common Stock

On ~~February 14, 2022,~~ ~~our Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend.~~ During the quarters ended September 30, 2022 and September 30, 2021, we declared dividends of $41 million and $42 million, respectively, or $0.2125 and $0.1875 per share, respectively, to common stockholders. During the quarters ended June 30, 2022 and 2021, we declared dividends of $44 million and $41 million, respectively, or $0.2125 and $0.1875 per share, respectively, to common stockholders. During the quarters ended and March 31, 2022and March 31, 2021,, we ~~paid~~declared dividends of $45 million and $36 million, respectively, or $0.2125 and $0.1625 per share, respectively, to common stockholders.

14. ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of other comprehensive (loss) income and changes in accumulated other comprehensive loss by component were as follows (dollars in millions):

Huntsman Corporation

				*Pension*			*Other*																*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*			*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*			*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*			*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*Corporation*			*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*Corporation*
Beginning balance, January 1, 2022	$	(420	)	$	(810	)	$	8	$	6		$	(1,216	)	$	13	$	(1,203	)	$	(420	)	$	(810	)	$	8	$	6		$	(1,216	)	$	13	$	(1,203	)
Other comprehensive loss before reclassifications, gross		(20	)		0			0		(1	)		(21	)		1		(20	)		(338	)		—			—		(1	)		(339	)		17		(322	)
Tax expense		0			0			0		0			0			0		0			—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			13			0		0			13			0		13			—			36			—		—			36			—		36
Tax expense		0			(4	)		0		0			(4	)		0		(4	)		—			(8	)		—		—			(8	)		—		(8	)
Net current-period other comprehensive (loss) income		(20	)		9			0		(1	)		(12	)		1		(11	)		(338	)		28			—		(1	)		(311	)		17		(294	)
Ending balance, March 31, 2022	$	(440	)	$	(801	)	$	8	$	5		$	(1,228	)	$	14	$	(1,214	)
Ending balance, September 30, 2022																				$	(758	)	$	(782	)	$	8	$	5		$	(1,527	)	$	30	$	(1,497	)

(a)	Amounts are net of tax of $56 million ~~for~~as of both ~~March 31,~~September 30, 2022 and January 1, 2022., respectively.

(b)	Amounts are net of tax of ~~$77~~$73 million and $81 million as of ~~March 31,~~September 30, 2022 and January 1, 2022, respectively.

(c)	See table below for details about these reclassifications.

				*Pension*			*Other*															*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*		*Amounts*			*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*		*attributable to*			*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*		*Huntsman*			*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*		*Corporation*			*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*Corporation*
Beginning balance, January 1, 2021	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20	$	(1,346	)	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20		$	(1,346	)
Other comprehensive loss before reclassifications, gross		(32	)		0			0		0		(32	)		0		(32	)		(42	)		—			—		—		(42	)		(2	)		(44	)
Tax expense		0			0			0		0		0			0		0			—			—			—		—		—			—			—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			24			0		0		24			0		24			—			65			—		—		65			—			65
Tax expense		0			(5	)		0		0		(5	)		0		(5	)		—			(13	)		—		—		(13	)		—			(13	)
Net current-period other comprehensive (loss) income		(32	)		19			0		0		(13	)		0		(13	)		(42	)		52			—		—		10			(2	)		8
Ending balance, March 31, 2021	$	(360	)	$	(1,031	)	$	8	$	4	$	(1,379	)	$	20	$	(1,359	)
Ending balance, September 30, 2021																			$	(370	)	$	(998	)	$	8	$	4	$	(1,356	)	$	18		$	(1,338	)

(a)	Amounts are net of tax of $56 million for both ~~March 31,~~September 30, 2021 and January 1, 2021.

(b)	Amounts are net of tax of ~~$148~~$139 million and $153 million as of ~~March 31,~~September 30, 2021 and January 1, 2021, respectively.

(c)	See table below for details about these reclassifications.

2427

Table of Contents

	*Three Months Ended March 31,*								*Three Months Ended September 30,*
	*2022*			*2021*					*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(2	)	$	(3	)	(b)	Other income, net	$	(3	)	$	(3	)	(b)(c)	Other income, net
Settlement loss		0			3		(b)	Other income, net
Actuarial loss		15			24		(b)(c)	Other income, net		15			23		(b)(c)	Other income, net
		13			24			Total before tax		12			20			Total before tax
		(4	)		(5	)		Income tax expense		(2	)		(3	)		Income tax expense
Total reclassifications for the period	$	9		$	19			Net of tax	$	10		$	17			Net of tax

	*Nine Months Ended September 30,*
	*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(8	)	$	(8	)	(b)(c)	Other income, net
Settlement loss		—			3		(b)	Other income, net
Actuarial loss		44			70		(b)(c)	Other income, net
		36			65			Total before tax
		(8	)		(13	)		Income tax expense
Total reclassifications for the period	$	28		$	52			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 12. Employee Benefit Plans.”

(c)

Amounts include approximately $1$3 million and $2$4 million of actuarial losses and prior service credits related to discontinued operations for the three months ended ~~March 31,~~September 30, 2022 and 2021, respectively. Amounts contain approximately $8 million and $12 million of actuarial losses and prior service credits related to discontinued operations for the nine months ended September 30, 2022 and 2021, respectively.

Huntsman International

				*Pension*			*Other*																*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*			*Foreign*			*and other*			*comprehensive*								*Amounts*		*Amounts*
	*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*			*currency*			*postretirement*			*income of*								*attributable to*		*attributable to*
	*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*			*translation*			*benefits*			*unconsolidated*								*noncontrolling*		*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*International*			*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*			*Total*			*interests*		*International*
Beginning balance, January 1, 2022	$	(424	)	$	(786	)	$	8	$	2		$	(1,200	)	$	13	$	(1,187	)	$	(424	)	$	(786	)	$	8	$	2		$	(1,200	)	$	13	$	(1,187	)
Other comprehensive loss before reclassifications, gross		(20	)		0			0		(1	)		(21	)		1		(20	)		(339	)		—			—		(1	)		(340	)		17		(323	)
Tax expense		0			0			0		0			0			0		0			—			—			—		—			—			—		—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			13			0		0			13			0		13			—			36			—		—			36			—		36
Tax expense		0			(4	)		0		0			(4	)		0		(4	)		—			(8	)		—		—			(8	)		—		(8	)
Net current-period other comprehensive (loss) income		(20	)		9			0		(1	)		(12	)		1		(11	)		(339	)		28			—		(1	)		(312	)		17		(295	)
Ending balance, March 31, 2022	$	(444	)	$	(777	)	$	8	$	1		$	(1,212	)	$	14	$	(1,198	)
Ending balance, September 30, 2022																				$	(763	)	$	(758	)	$	8	$	1		$	(1,512	)	$	30	$	(1,482	)

(a)	Amounts are net of tax of $43 million ~~for both~~as of ~~March 31,~~September 30, 2022 and January 1, 2022., respectively.

(b)	Amounts are net of tax of ~~$101~~$97 million and $105 million as of ~~March 31,~~September 30, 2022 and January 1, 2022, respectively.

(c)	See table below for details about these reclassifications.

2528

Table of Contents

				*Pension*			*Other*															*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*		*Amounts*			*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*		*attributable to*			*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*		*Huntsman*			*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*		*International*			*adjustments(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*International*
Beginning balance, January 1, 2021	$	(333	)	$	(1,028	)	$	8	$	0	$	(1,353	)	$	20	$	(1,333	)	$	(333	)	$	(1,028	)	$	8	$	—	$	(1,353	)	$	20		$	(1,333	)
Other comprehensive loss before reclassifications, gross		(31	)		0			0		0		(31	)		0		(31	)		(42	)		—			—		—		(42	)		(2	)		(44	)
Tax expense		0			0			0		0		0			0		0			—			—			—		—		—			—			—
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			25			0		0		25			0		25			—			67			—		—		67			—			67
Tax expense		0			(6	)		0		0		(6	)		0		(6	)		—			(14	)		—		—		(14	)		—			(14	)
Net current-period other comprehensive (loss) income		(31	)		19			0		0		(12	)		0		(12	)		(42	)		53			—		—		11			(2	)		9
Ending balance, March 31, 2021	$	(364	)	$	(1,009	)	$	8	$	0	$	(1,365	)	$	20	$	(1,345	)
Ending balance, September 30, 2021																			$	(375	)	$	(975	)	$	8	$	—	$	(1,342	)	$	18		$	(1,324	)

(a)	Amounts are net of tax of $43 million as of both ~~March 31,~~September 30, 2021 and January 1, 2021.

(b)	Amounts are net of tax of ~~$172~~$164 million and $178 million as of ~~March 31,~~September 30, 2021 and January 1, 2021, respectively.

(c)	See table below for details about these reclassifications.

	*Three Months Ended March 31,*								*Three Months Ended September 30,*
	*2022*			*2021*					*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(2	)	$	(3	)	(b)	Other income, net	$	(3	)	$	(3	)	(b)(c)	Other income, net
Settlement loss		0			3		(b)	Other income, net
Actuarial loss		15			25		(b)(c)	Other income, net		15			24		(b)(c)	Other income, net
		13			25			Total before tax		12			21			Total before tax
		(4	)		(6	)		Income tax expense		(2	)		(4	)		Income tax expense
Total reclassifications for the period	$	9		$	19			Net of tax	$	10		$	17			Net of tax

	*Nine Months Ended September 30,*
	*2022*			*2021*
	*Amounts reclassified*			*Amounts reclassified*				*Affected line item in*
	*from accumulated*			*from accumulated*				*the statement*
Details about accumulated other	*other*			*other*				*where net income*
comprehensive loss components(a):	*comprehensive loss*			*comprehensive loss*				*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(8	)	$	(8	)	(b)(c)	Other income, net
Settlement loss		—			3		(b)	Other income, net
Actuarial loss		44			72		(b)(c)	Other income, net
		36			67			Total before tax
		(8	)		(14	)		Income tax expense
Total reclassifications for the period	$	28		$	53			Net of tax

(a)	Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(b)	These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 12. Employee Benefit Plans.”

(c)

Amounts include approximately $1$3 million and $2$4 million ~~respectively,~~of actuarial losses and prior service credits related to discontinued operations for the three months ended September 30, 2022 and 2021, respectively. Amounts contain approximately $8 million and $12 million of actuarial losses related to discontinued operations for ~~both~~ the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021.

, respectively.

2629

Table of Contents

15. COMMITMENTS AND CONTINGENCIES

Legal Matters

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After the court applies the appropriate amount of interest, we expect that total damages awarded to us will exceed $125 million. The award is subject to appeal, and as such, we have not yet recognized the award in our condensed consolidated statements of operations and the timing of the resolution of this matter is unknown.

We are a party to various other proceedings instituted by private plaintiffs, governmental authorities and others arising under provisions of applicable laws, including various environmental, products liability and other laws. Except as otherwise disclosed in this report, we do not believe that the outcome of any of these matters will have a material effect on our financial condition, results of operations or liquidity.

16. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS

~~EHS~~EHS Capital Expenditures

We may incur future costs for capital improvements and general compliance under environmental, health and safety (“EHS”) laws, including costs to acquire, maintain and repair pollution control equipment. For ~~both~~ the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, our capital expenditures from continuing operations for EHS matters totaled ~~$7 million.~~$27 million and $21 million, respectively. Because capital expenditures for these matters are subject to evolving regulatory requirements and depend, in part, on the timing, promulgation and enforcement of specific requirements, our capital expenditures for EHS matters have varied significantly from year to year and we cannot provide assurance that our recent expenditures are indicative of future amounts we may spend related to EHS and other applicable laws.

Environmental Reserves

We have accrued liabilities relating to anticipated environmental cleanup obligations, site reclamation and closure costs and known penalties. Liabilities are recorded when potential liabilities are either known or considered probable and can be reasonably estimated. Our liability estimates are calculated using present value techniques as appropriate and are based upon requirements placed upon us by regulators, available facts, existing technology and past experience. The environmental liabilities do not include amounts recorded as asset retirement obligations. We had accrued $4 million and $5 million for environmental liabilities for ~~both~~ ~~March 31,~~September 30, 2022 and December 31, 2021., respectively. Of these amounts, $1 million was classified as accrued liabilities in our condensed consolidated balance sheets for both ~~March 31,~~September 30, 2022 and December 31, 2021, and $3 million and $4 million were classified as other noncurrent liabilities in our condensed consolidated balance sheets for ~~both~~ ~~March 31,~~September 30, 2022 and December 31, 2021., respectively. In certain cases, our remediation liabilities may be payable over periods of up to 30 years. We may incur losses for environmental remediation in excess of the amounts accrued; however, we are not able to estimate the amount or range of such potential excess.

Environmental Matters

Under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and similar state laws, a current or former owner or operator of real property in the U.S. may be liable for remediation costs regardless of whether the release or disposal of hazardous substances was in compliance with law at the time it occurred, and a current owner or operator may be liable regardless of whether it owned or operated the facility at the time of the release. Outside the U.S., analogous contaminated property laws, such as those in effect in France and Australia, can hold past owners and/or operators liable for remediation at former facilities. Currently, there are approximately 9nine former facilities or third-party sites in the U.S. for which we have been notified of potential claims against us for cleanup liabilities, including, but not limited to, sites listed under CERCLA. Based on current information and past experiences at other CERCLA sites, we do not expect these third-party claims to have a material impact on our condensed consolidated financial statements.

Under the Resource Conservation and Recovery Act (“RCRA”) in the U.S. and similar state laws, we may be required to remediate contamination originating from our properties as a condition to our hazardous waste permit. Some of our manufacturing sites have an extended history of industrial chemical manufacturing and use, including on-site waste disposal. We are aware of soil, groundwater or surface contamination from past operations at some of our sites, and we may find contamination at other sites in the future. For example, our Geismar, Louisiana facility is the subject of ongoing remediation requirements imposed under RCRA. Similar laws exist in a number of locations in which we currently operate, or previously operated, manufacturing facilities, such as Australia, India, France, Hungary and Italy.

North Maybe Canyon Mine Remediation

The North Maybe Canyon Mine site is a CERCLA site and involves a former phosphorous mine near Soda Springs, Idaho, which is believed to have been operated by several companies, including a predecessor company to us. In 2004, the U.S. Forest Service notified us that we are a CERCLA potentially responsible party (“PRP”) for contamination originating from the site. In February 2010, we and Wells Cargo (another PRP) agreed to conduct a Remedial Investigation/Feasibility Study of a portion of the site and are currently engaged in that process. At this time, we are unable to reasonably estimate our potential liabilities at this site.

2730

Table of Contents

17. STOCK-BASED COMPENSATION PLANS

As of ~~March 31,~~September 30, 2022, we had approximately 6 million shares remaining under the stock-based compensation plans available for grant. Option awards have a maximum contractual term of 10 years and generally must have an exercise price at least equal to the market price of our common stock on the date the option award is granted. Outstanding stock-based awards generally vest annually over a three-year period or in total at the end of a three-year period. Certain performance share unit awards vest in total at the end of a two-year period.

The compensation cost from continuing operations under the stock-based compensation plans for our Company and Huntsman International were as follows (dollars in millions):

	*Three months*				*Three months*				*Nine months*
	*ended*				*ended*				*ended*
	*March 31,*				*September 30,*				*September 30,*
	*2022*		*2021*		*2022*		*2021*		*2022*		*2021*
Huntsman Corporation compensation cost	$	11	$	9	$	6	$	8	$	26	$	23
Huntsman International compensation cost		9		8		6		8		24		22

The total income tax benefit recognized in the condensed consolidated statements of operations for us and Huntsman International for stock-based compensation arrangements was $4$7 million and $1$2 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, respectively.

Stock Options

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of our common stock through the grant date. The expected term of options granted was estimated based on the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. The assumptions noted below represent the weighted average of the assumptions utilized for stock options granted during the periods.

	*~~Three~~Nine months*
	*ended*
	*~~March 31,~~September 30,*
	*2022(1)*	*~~2021~~2021(2)*
Dividend yield	NA		2.3	%
Expected volatility	NA		53.3	%
Risk-free interest rate	NA		0.7	%
Expected life of stock options granted during the period (in years)	NA		5.9

(1)	During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, 0no stock options were granted.
(2)	During the nine months ended September 30, 2021, stock options were only granted during the first quarter.

A summary of stock option activity under the stock-based compensation plans as of ~~March 31,~~September 30, 2022 and changes during the ~~three~~nine months then ended is presented below:

						*Weighted*									*Weighted*
				*Weighted*		*average*							*Weighted*		*average*
				*average*		*remaining*		*Aggregate*					*average*		*remaining*		*Aggregate*
				*exercise*		*contractual*		*intrinsic*					*exercise*		*contractual*		*intrinsic*
Option awards	*Shares*			*price*		*term*		*value*		*Shares*			*price*		*term*		*value*
	(in thousands)					(years)		(in millions)		(in thousands)					(years)		(in millions)
Outstanding at January 1, 2022		4,054		$	21.62						4,054		$	21.62
Granted		0			0						—			—
Exercised		(515	)		19.46						(597	)		19.63
Forfeited		(19	)		26.68						(31	)		25.61
Outstanding at March 31, 2022		3,520			21.91		5.4	$	55
Exercisable at March 31, 2022		3,092			21.56		4.9		49
Outstanding at September 30, 2022											3,426			21.93		5.0	$	13
Exercisable at September 30, 2022											3,016			21.58		4.6		12

2831

Table of Contents

As of ~~March 31,~~September 30, 2022, there was approximately $4$2 million of total unrecognized compensation cost related to nonvested stock option arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~1.5~~1.1 years.

The total intrinsic value of stock options exercised during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was approximately ~~$11~~$12 million and $3$8 million, respectively. Cash received from stock options exercised during ~~each~~both of the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was approximately ~~$5 million and $3 million, respectively.~~$6 million. The cash tax benefit from stock options exercised during ~~each~~both of the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was approximately $2 ~~million and $1 million, respectively.~~million.

Nonvested Shares

Nonvested shares granted under the stock-based compensation plans consist of restricted stock and performance share unit awards, which are accounted for as equity awards, and phantom stock, which is accounted for as a liability award because it can be settled in either stock or cash. The fair value of each restricted stock and phantom stock award is estimated to be the closing stock price of Huntsman’s stock on the date of grant.

We grant two types of performance share unit awards. For one type of performance share unit award, the performance criteria are total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the three-year performance periods. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, the weighted-average expected volatility rate was 43.5% and ~~44.8%~~44.9%, respectively, and the weighted average risk-free interest rate was 1.67% and 0.2%, respectively. For the performance share unit awards granted induring the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, the number of shares earned varies based upon the Company achieving certain performance criteria over a three-year performance period.

During the first quarter of 2022, we began issuing a second type of performance award, which also includes a market condition. The performance criteria are our corporate free cash flow achieved relative to targets set by management, modified for the total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the two-year performance period. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the ~~three~~nine months ended ~~March 31,~~September 30, 2022, the weighted-average expected volatility rate was 37.9% and the weighted average risk-free interest rate was 1.43%. For the performance share unit awards granted induring the ~~three~~nine months ended ~~March 31,~~September 30, 2022~~and~~ ~~2021~~, the number of shares earned varies based upon the Company achieving certain performance criteria over a two-year performance period.

A summary of the status of our nonvested shares as of ~~March 31,~~September 30, 2022 and changes during the ~~three~~nine months then ended is presented below:

	*Equity awards*						*Liability awards*					*Equity awards*						*Liability awards*
					*Weighted*					*Weighted*						*Weighted*					*Weighted*
					*average*					*average*						*average*					*average*
					*grant-date*					*grant-date*						*grant-date*					*grant-date*
	*Shares*				*fair value*		*Shares*			*fair value*		*Shares*				*fair value*		*Shares*			*fair value*
	(in thousands)						(in thousands)					(in thousands)						(in thousands)
Nonvested at January 1, 2022		2,178			$	25.07		367		$	24.91		2,178			$	25.07		367		$	24.91
Granted		712				48.12		102			41.04		716				48.00		102			41.04
Vested		(1,044	)	⁽¹⁾⁽²⁾		23.11		(187	)		24.04		(1,056	)	⁽¹⁾⁽²⁾		23.12		(188	)		24.00
Forfeited		(14	)			26.13		(4	)		25.85		(30	)			31.61		(17	)		28.35
Nonvested at March 31, 2022		1,832				35.13		278			31.38
Nonvested at September 30, 2022													1,808				35.18		264			31.57

(1)

As of ~~March 31,~~September 30, 2022, a total of 106,285 restricted stock units were vested but not yet issued, of which 7,066 vested during the ~~three~~nine months ended ~~March 31,~~September 30, 2022. These shares have not been reflected as vested shares in this table because, in accordance with the restricted stock unit agreements, shares of common stock are not issued for vested restricted stock units until termination of employment.

(2)

A total of 193,623 performance share unit awards are reflected in the vested shares in this table, which represents the target number of performance share unit awards for this grant and were included in the balance at December 31, 2021. During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, an additional 96,814 performance share unit awards with a grant date fair value of $29.68 were issued due to the target performance criteria being exceeded.

As of ~~March 31,~~September 30, 2022, there was approximately ~~$57~~$39 million of total unrecognized compensation cost related to nonvested share compensation arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~2.1~~1.8 years. The value of share awards that vested during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was approximately ~~$31~~$32 million and $18 million, respectively.

2932

Table of Contents

18. INCOME TAXES

We use the asset and liability method of accounting for income taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial and tax reporting purposes. We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed on an individual tax jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider the cyclicality of our businesses and cumulative income or losses during the applicable period. Cumulative losses incurred over the applicable period limits our ability to consider other subjective evidence such as our projections for the future. Changes in expected future income in applicable jurisdictions could affect the realization of deferred tax assets in those jurisdictions.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, there was 0no tax benefit or expense recognized in connection with the net losses of $2$9 million and ~~$19~~$28 million, respectively, on fair value adjustments to our Venator investment and related option to sell our remaining Venator shares recorded as part of non-operating income from continuing operations. Through December 31, 2021, we have recognized the portion of our Venator investment tax basis in excess of book that we ultimately expect to be able to utilize; no incremental tax benefit has been recognized on the year-to-date fair value losses incurred in 2021 or 2022. As a significant, unusual and non-operating item, these amounts were treated discretely and excluded from the annual effective tax rate calculation for interim reporting.

Huntsman Corporation

We recorded income tax expense from continuing operations of ~~$65~~$155 million and ~~$34~~$101 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

Huntsman International

Huntsman International recorded income tax expense from continuing operations of ~~$65~~$156 million and ~~$35~~$102 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

19. EARNINGS PER SHARE

Basic income per share excludes dilution and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period. Diluted income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities.

Basic and diluted income per share is determined using the following information (in millions):

	*Three months*				*Three months*				*Nine months*
	*ended*				*ended*				*ended*
	*March 31,*				*September 30,*				*September 30,*
	*2022*		*2021*		*2022*		*2021*		*2022*		*2021*
Numerator:
Income from continuing operations attributable to Huntsman Corporation	$	222	$	82	$	101	$	203	$	521	$	412
Net income attributable to Huntsman Corporation	$	223	$	83	$	100	$	209	$	551	$	448

Denominator:
Weighted average shares outstanding		212.7		220.4		197.7		219.4		205.2		220.2
Dilutive shares:
Stock-based awards		2.7		2.2		1.5		1.9		2.0		2.0
Total weighted average shares outstanding, including dilutive shares		215.4		222.6		199.2		221.3		207.2		222.2

Additional stock-based awards of approximately ~~0.4~~1.3 million and ~~1.1~~1.0 million weighted average equivalent shares of stock were outstanding during the three months ended ~~March 31,~~September 30, 2022 and 2021, respectively, and approximately 0.9 million and 1.5 million weighted average equivalent shares of stock were outstanding during the nine months ended September 30, 2022 and 2021, respectively. However, these stock-based awards were not included in the computation of diluted income per share for the respective periods mentioned above because the effect would be anti-dilutive.

3033

Table of Contents

20. OPERATING SEGMENT INFORMATION

We derive our revenues, earnings and cash flows from the manufacture and sale of a wide variety of differentiated and commodity chemical products. We have 4three operating segments, which are also our reportable segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. We have organized our business and derived our operating segments around differences in product lines. Beginning in the third quarter of 2022, the results of our Textile Effects Business are reported as discontinued operations in our condensed consolidated financial statements for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business.”

The major products of each reportable operating segment are as follows:

Segment		Products
Polyurethanes		MDI, polyols, TPU and other polyurethane-related products
Performance Products		Specialty amines, ethyleneamines, maleic anhydride and technology licenses
Advanced Materials		Specialty resin compounds; cross-linking, matting, and curing and toughening agents; epoxy, acrylic and polyurethane-based formulations; specialty nitrile latex, alkyd resins and carbon nano materials
~~Textile Effects~~		~~Textile chemicals and dyes~~

Sales between segments are generally recognized at external market prices and are eliminated in consolidation. We use adjusted EBITDA to measure the financial performance of our global business units and for reporting the results of our operating segments. This measure includes all operating items relating to the businesses. The adjusted EBITDA of operating segments excludes items that principally apply to our Company as a whole. The following schedule includes revenues and adjusted EBITDA for each of our reportable operating segments (dollars in millions). We have revised our prior ~~years’~~year presentation below to reconcile total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes, in addition to net income, and removed “corporate and other costs, net” from the total reportable segments’ adjusted EBITDA and included such amounts in the reconciliation to income from continuing operations before income taxes. Additionally, we have revised our prior ~~years’~~year presentation of total reportable segments’ revenues, in which we removed intersegment eliminations from the total reportable ~~segment’s~~segments’ revenues.

	*Three months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*
	*March 31,*						*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*			*2022*			*2021*
Revenues:
Polyurethanes	$	1,386		$	1,068		$	1,257		$	1,403		$	3,996		$	3,626
Performance Products		480			305			434			399			1,406			1,075
Advanced Materials		335			278			328			304			999			881
Textile Effects		197			193
Total reportable segment’s revenue		2,398			1,844
Total reportable segments’ revenue								2,019			2,106			6,401			5,582
Intersegment eliminations		(9	)		(7	)		(8	)		(9	)		(28	)		(24	)
Total	$	2,389		$	1,837		$	2,011		$	2,097		$	6,373		$	5,558

Huntsman Corporation:
Segment adjusted EBITDA(1):
Polyurethanes	$	224		$	207		$	138		$	246		$	591		$	661
Performance Products		146			63			110			103			408			254
Advanced Materials		67			44			58			48			192			150
Textile Effects		28			25
Total reportable segments’ adjusted EBITDA		465			339			306			397			1,191			1,065

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(14	)		(19	)		(16	)		(15	)		(46	)		(52	)
Depreciation and amortization—continuing operations		(71	)		(74	)		(72	)		(68	)		(207	)		(205	)
Corporate and other costs, net(2)		(50	)		(50	)		(35	)		(48	)		(123	)		(146	)
Net income attributable to noncontrolling interests		17			17			15			16			46			49
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(6	)		(9	)		(1	)		(5	)		(11	)		(19	)
Fair value adjustments to Venator investment		(2	)		(19	)
Fair value adjustments to Venator investment, net								(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt								—			—			—			(27	)
Certain legal and other settlements and related expenses		(12	)		(2	)		(1	)		—			(15	)		(10	)
Costs associated with the Albemarle Settlement, net		(1	)		0			(1	)		—			(3	)		—
Loss on sale of business/assets		(4	)		0
(Loss) gain on sale of business/assets								(16	)		—			(27	)		30
Income from transition services arrangements		1			1			—			2			2			6
Certain nonrecurring information technology project implementation costs		(2	)		(1	)		(1	)		(2	)		(4	)		(6	)
Amortization of pension and postretirement actuarial losses		(14	)		(22	)		(10	)		(19	)		(32	)		(56	)
Plant incident remediation costs		0			(4	)
Plant incident remediation (costs) credits								(1	)		(2	)		4			(3	)
Restructuring, impairment and plant closing and transition costs(3)		(3	)		(24	)		(14	)		—			(44	)		(36	)
Income from continuing operations before income taxes		304			133			146			253			722			562

Income tax expense—continuing operations		(65	)		(34	)		(30	)		(34	)		(155	)		(101	)
Income from discontinued operations		1			1
(Loss) income from discontinued operations								(1	)		6			30			36
Net income	$	240		$	100		$	115		$	225		$	597		$	497

3134

Table of Contents

	*Three months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*
	*March 31,*						*September 30,*						*September 30,*
	*2022*			*2021*			*2022*			*2021*			*2022*			*2021*
Huntsman International:
Segment adjusted EBITDA(1):
Polyurethanes	$	224		$	207		$	138		$	246		$	591		$	661
Performance Products		146			63			110			103			408			254
Advanced Materials		67			44			58			48			192			150
Textile Effects		28			25
Total reportable segments’ adjusted EBITDA		465			339			306			397			1,191			1,065

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:
Interest expense, net—continuing operations		(14	)		(19	)		(16	)		(15	)		(46	)		(52	)
Depreciation and amortization—continuing operations		(71	)		(73	)		(72	)		(68	)		(207	)		(205	)
Corporate and other costs, net(2)		(47	)		(47	)		(36	)		(47	)		(119	)		(140	)
Net income attributable to noncontrolling interests		17			17			15			16			46			49
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		(6	)		(9	)		(1	)		(5	)		(11	)		(19	)
Fair value adjustments to Venator investment		(2	)		(19	)
Fair value adjustments to Venator investment, net								(7	)		(3	)		(9	)		(28	)
Loss on early extinguishment of debt								—			—			—			(27	)
Certain legal and other settlements and related expenses		(12	)		(2	)		(1	)		—			(15	)		(10	)
Costs associated with the Albemarle Settlement, net		(1	)		0			(1	)		—			(3	)		—
Loss on sale of business/assets		(4	)		0
(Loss) gain on sale of business/assets								(16	)		—			(27	)		30
Income from transition services arrangements		1			1			—			2			2			6
Certain nonrecurring information technology project implementation costs		(2	)		(1	)		(1	)		(2	)		(4	)		(6	)
Amortization of pension and postretirement actuarial losses		(14	)		(23	)		(10	)		(19	)		(32	)		(58	)
Plant incident remediation costs		0			(4	)
Plant incident remediation (costs) credits								(1	)		(2	)		4			(3	)
Restructuring, impairment and plant closing and transition costs(3)		(3	)		(24	)		(14	)		—			(44	)		(36	)
Income from continuing operations before income taxes		307			136			145			254			726			566

Income tax expense—continuing operations		(65	)		(35	)		(30	)		(35	)		(156	)		(102	)
Income from discontinued operations		1			1
(Loss) income from discontinued operations								(1	)		6			30			36
Net income	$	243		$	102		$	114		$	225		$	600		$	500

(1)

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests, ~~and~~ certain Corporate and other items and income from discontinued operations, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) fair value adjustments to Venator ~~investment;~~investment, net; (c) loss on early extinguishment of debt; (d) certain legal and other settlements and related ~~income (expenses); (d)~~expenses; (e) costs associated with the Albemarle Settlement, net; ~~(e) loss~~(f) (loss) gain on sale of business/assets; ~~(f)~~(g) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(g)~~(h) certain nonrecurring information technology project implementation costs; ~~(h)~~(i) amortization of pension and postretirement actuarial losses; ~~(i)~~(j) plant incident remediation ~~costs;~~credits (costs); and ~~(j)~~(k) restructuring, impairment, plant closing and transition costs.

(2)

Corporate and other costs, ~~(net)~~net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets.

(3)	Includes costs associated with transition activities ~~relating~~related primarily to our Corporate program to optimize our global approach to leverage shared services capabilities.

3235

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We operate in ~~four~~three segments: Polyurethanes, Performance Products and Advanced ~~Materials and Textile Effects.~~Materials. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining and synthetic fiber ~~textile chemicals and dyes~~ industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer ~~formulations, textile chemicals and dyes.~~formulations. Our revenues from continuing operations for the three months ended ~~March 31,~~September 30, 2022 and 2021 were ~~$2,389~~$2,011 million and ~~$1,837~~$2,097 million, respectively, and for the nine months ended September 30, 2022 and 2021 were $6,373 million and $5,558 million, respectively.

Recent Developments

~~Share Repurchase~~

European Restructuring Program

In early November 2022, we announced our commitment and specific plans to further realign our cost structure beyond the current in-progress cost optimization programs with additional restructuring in Europe. The new program will include exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this program, we expect to record restructuring expenses of approximately $50 million through 2023.

Sale of Textile Effects Business

On ~~March 25,~~August 9, 2022, we entered into a definitive agreement to sell our ~~Board~~Textile Effects Business to Archroma for a total enterprise value of ~~Directors increased~~$718 million, which includes the ~~authorization~~assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. We anticipate the transaction will close no later than the first half of 2023. Beginning in the third quarter of 2022, the results of our ~~existing share repurchase program from $1 billion~~Textile Effects Business are reported as discontinued operations for all periods presented. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business” to $2 billion. Repurchases may be made through the open market or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost.

~~Dividend Increase~~

~~On February 14, 2022,~~ our ~~Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend.~~

condensed consolidated financial statements.

3336

Table of Contents

Outlook

We expect the following factors to impact our operating segments:

Polyurethanes:

●

~~Second~~Fourth quarter 2022 adjusted EBITDA estimated to be between ~~$210~~$55 million and ~~$230~~$85 million

●

~~Positive trends in our insulation business,~~European profitability negatively driven by ~~commercial~~high energy prices and declining demand

●

Americas end markets weaker, particularly in construction

	●	Modest increase in automotive market sales volumes year-over-year
	●	~~Higher costs, specifically in Europe, remain a headwind~~
	●	~~China sales volumes pressure due~~Lower production rates to ~~COVID-19 related lockdowns~~reduce inventory and match lower demand

Performance Products:

●

~~Second~~Fourth quarter 2022 adjusted EBITDA estimated to be between ~~$130~~$60 million and ~~$140~~$80 million

●

~~Commercial initiatives~~Lower sales volumes year-over-year, primarily in Europe and ~~solid demand drive year-over-year improvement~~in construction markets

●

~~China sales volumes lower quarter-over-quarter due~~

Adjusted EBITDA margin expected to ~~COVID-19 related lockdowns~~be within 20% to 25%

Advanced Materials:

●

~~Second~~Fourth quarter 2022 adjusted EBITDA estimated to be between ~~$62~~$40 million and ~~$68~~$45 million

	●	~~Pricing increases to offset higher raw material costs~~
	●	~~Industrial~~Automotive and aerospace markets ~~in Europe and Americas regions~~ remain stable
	●	~~China demand lower quarter-over-quarter due to COVID-19 related lockdowns~~

~~Textile Effects~~

●

~~Second quarter 2022 adjusted EBITDA estimated to be between $29 million and $31 million~~

	●	~~Second quarter 2022 seasonally strongest quarter benefitting from positive trends in sustainability~~
	●	~~Sales volumes~~ Demand headwinds in ~~North Asia~~industrial markets ~~due to COVID-19 related lockdowns in China~~

In the ~~first~~third quarter of 2022, both our effective tax rate and our adjusted effective tax rate were 21%. For 2022, our adjusted effective tax rate is expected to be approximately 22% to 24%. For further information, see “—Non-GAAP Financial Measures” and “Note 18. Income Taxes” to our condensed consolidated financial statements.

Refer to “Forward-Looking Statements” for a discussion of our use of forward-looking statements in this Quarterly Report on Form 10-Q.

3437

Table of Contents

Results of Operations

For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations from continuing operations (dollars in millions, except per share amounts):

Huntsman Corporation

	Three months									Three months									Nine months
	ended									ended									ended
	March 31,						Percent			September 30,						Percent			September 30,						Percent
	2022			2021			change			2022			2021			change			2022			2021			change
Revenues	$	2,389		$	1,837			30	%	$	2,011		$	2,097			(4	)%	$	6,373		$	5,558			15	%
Cost of goods sold		1,824			1,445			26	%		1,662			1,660			—			5,017			4,397			14	%
Gross profit		565			392			44	%		349			437			(20	)%		1,356			1,161			17	%
Operating expenses, net		261			242			8	%		199			208			(4	)%		621			597			4	%
Restructuring, impairment and plant closing costs		—			24			(100	)%
Restructuring, impairment and plant closing costs (credits)											12			(1	)		NM			36			34			6	%
Operating income		304			126			141	%		138			230			(40	)%		699			530			32	%
Interest expense, net		(14	)		(19	)		(26	)%		(16	)		(15	)		7	%		(46	)		(52	)		(12	)%
Equity in income of investment in unconsolidated affiliates		15			38			(61	)%		21			34			(38	)%		55			118			(53	)%
Fair value adjustments to Venator investment		(2	)		(19	)		(89	)%
Fair value adjustments to Venator investment, net											(7	)		(3	)		133	%		(9	)		(28	)		(68	)%
Loss on early extinguishment of debt											—			—			—			—			(27	)		(100	)%
Other income, net		1			7			(86	)%		10			7			43	%		23			21			10	%
Income from continuing operations before income taxes		304			133			129	%		146			253			(42	)%		722			562			28	%
Income tax expense		(65	)		(34	)		91	%		(30	)		(34	)		(12	)%		(155	)		(101	)		53	%
Income from continuing operations		239			99			141	%		116			219			(47	)%		567			461			23	%
Income from discontinued operations, net of tax(1)		1			1			—
(Loss) income from discontinued operations, net of tax											(1	)		6			NM			30			36			(17	)%
Net income		240			100			140	%		115			225			(49	)%		597			497			20	%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(17	)		(17	)		—			(15	)		(16	)		(6	)%		(46	)		(49	)		(6	)%
Interest expense, net from continuing operations		14			19			(26	)%		16			15			7	%		46			52			(12	)%
Income tax expense from continuing operations		65			34			91	%		30			34			(12	)%		155			101			53	%
Income tax expense from discontinued operations											7			9			(22	)%		14			18			(22	)%
Depreciation and amortization from continuing operations		71			74			(4	)%		72			68			6	%		207			205			1	%
Depreciation and amortization from discontinued operations											3			4			(25	)%		11			14			(21	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		6			9						1			5						11			19
EBITDA from discontinued operations(1)		(1	)		(1	)
Fair value adjustments to Venator investment		2			19
EBITDA from discontinued operations											(9	)		(19	)					(55	)		(68	)
Fair value adjustments to Venator investment, net											7			3						9			28
Loss on early extinguishment of debt											—			—						—			27
Certain legal and other settlements and related expenses		12			2						1			—						15			10
Costs associated with the Albemarle Settlement, net		1			—						1			—						3			—
Loss on sale of business/assets		4			—
Loss (gain) on sale of business/assets											16			—						27			(30	)
Income from transition services arrangements		(1	)		(1	)					—			(2	)					(2	)		(6	)
Certain nonrecurring information technology project implementation costs		2			1						1			2						4			6
Amortization of pension and postretirement actuarial losses		14			22						10			19						32			56
Plant incident remediation costs		—			4
Restructuring, impairment and plant closing and transition costs		3			24
Adjusted EBITDA(2)	$	415		$	289			44	%
Plant incident remediation costs (credits)											1			2						(4	)		3
Restructuring, impairment and plant closing and transition costs(2)											14			—						44			36
Adjusted EBITDA(1)										$	271		$	349			(22	)%	$	1,068		$	919			16	%

Net cash provided by (used in) operating activities from continuing operations	$	85		$	(16	)		NM
Net cash used in investing activities		(65	)		(323	)		(80	)%
Net cash provided by operating activities from continuing operations																			$	595		$	182			227	%
Net cash used in investing activities from continuing operations																				(176	)		(430	)		(59	)%
Net cash used in financing activities		(252	)		(579	)		(56	)%											(905	)		(809	)		12	%
Capital expenditures		(69	)		(98	)		(30	)%
Capital expenditures from continuing operations																				(186	)		(241	)		(23	)%

3538

Table of Contents

Huntsman International

	Three months									Three months									Nine months
	ended									ended									ended
	March 31,						Percent			September 30,						Percent			September 30,						Percent
	2022			2021			change			2022			2021			change			2022			2021			change
Revenues	$	2,389		$	1,837			30	%	$	2,011		$	2,097			(4	)%	$	6,373		$	5,558			15	%
Cost of goods sold		1,824			1,445			26	%		1,662			1,660			—			5,017			4,397			14	%
Gross profit		565			392			44	%		349			437			(20	)%		1,356			1,161			17	%
Operating expenses, net		258			239			8	%		200			207			(3	)%		617			591			4	%
Restructuring, impairment and plant closing costs		—			24			(100	)%
Restructuring, impairment and plant closing costs (credits)											12			(1	)		NM			36			34			6	%
Operating income		307			129			138	%		137			231			(41	)%		703			536			31	%
Interest expense, net		(14	)		(19	)		(26	)%		(16	)		(15	)		7	%		(46	)		(52	)		(12	)%
Equity in income of investment in unconsolidated affiliates		15			38			(61	)%		21			34			(38	)%		55			118			(53	)%
Fair value adjustments to Venator investment		(2	)		(19	)		(89	)%
Fair value adjustments to Venator investment, net											(7	)		(3	)		133	%		(9	)		(28	)		(68	)%
Loss on early extinguishment of debt											—			—			—			—			(27	)		(100	)%
Other income, net		1			7			(86	)%		10			7			43	%		23			19			21	%
Income from continuing operations before income taxes		307			136			126	%		145			254			(43	)%		726			566			28	%
Income tax expense		(65	)		(35	)		86	%		(30	)		(35	)		(14	)%		(156	)		(102	)		53	%
Income from continuing operations		242			101			140	%		115			219			(47	)%		570			464			23	%
Income from discontinued operations, net of tax(1)		1			1			—
(Loss) income from discontinued operations, net of tax											(1	)		6			NM			30			36			(17	)%
Net income		243			102			138	%		114			225			(49	)%		600			500			20	%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(17	)		(17	)		—			(15	)		(16	)		(6	)%		(46	)		(49	)		(6	)%
Interest expense, net from continuing operations		14			19			(26	)%		16			15			7	%		46			52			(12	)%
Income tax expense from continuing operations		65			35			86	%		30			35			(14	)%		156			102			53	%
Income tax expense from discontinued operations											7			9			(22	)%		14			18			(22	)%
Depreciation and amortization from continuing operations		71			73			(3	)%		72			68			6	%		207			205			1	%
Depreciation and amortization from discontinued operations											3			4			(25	)%		11			14			(21	)%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		6			9						1			5						11			19
EBITDA from discontinued operations(1)		(1	)		(1	)
Fair value adjustments to Venator investment		2			19
EBITDA from discontinued operations											(9	)		(19	)					(55	)		(68	)
Fair value adjustments to Venator investment, net											7			3						9			28
Loss on early extinguishment of debt											—			—						—			27
Certain legal and other settlements and related expenses		12			2						1			—						15			10
Costs associated with the Albemarle Settlement, net		1			—						1			—						3			—
Loss on sale of business/assets		4			—
Loss (gain) on sale of business/assets											16			—						27			(30	)
Income from transition services arrangements		(1	)		(1	)					—			(2	)					(2	)		(6	)
Certain nonrecurring information technology project implementation costs		2			1						1			2						4			6
Amortization of pension and postretirement actuarial losses		14			23						10			19						32			58
Plant incident remediation costs		—			4
Restructuring, impairment and plant closing and transition costs		3			24
Adjusted EBITDA(2)	$	418		$	292			43	%
Plant incident remediation costs (credits)											1			2						(4	)		3
Restructuring, impairment and plant closing and transition costs(2)											14			—						44			36
Adjusted EBITDA(1)										$	270		$	350			(23	)%	$	1,072		$	925			16	%

Net cash provided by (used in) operating activities from continuing operations	$	86		$	(17	)		NM
Net cash used in investing activities		(278	)		(330	)		(16	)%
Net cash provided by operating activities from continuing operations																			$	597		$	186			221	%
Net cash used in investing activities from continuing operations																				(942	)		(535	)		76	%
Net cash used in financing activities		(39	)		(575	)		(93	)%											(139	)		(706	)		(80	)%
Capital expenditures from continuing operations		(69	)		(98	)		(30	)%											(186	)		(241	)		(23	)%

3639

Table of Contents

Huntsman Corporation

	Three months									Three months									Three months									Three months
	ended									ended									ended									ended
	March 31, 2022									March 31, 2021									September 30, 2022									September 30, 2021
				Tax and									Tax and									Tax and									Tax and
	Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net			Gross			other(3)			Net
Reconciliation of net income to adjusted net income
Net income							$	240								$	100								$	115								$	225
Net income attributable to noncontrolling interests								(17	)								(17	)								(15	)								(16	)
Business acquisition and integration expenses and purchase accounting inventory adjustments	$	6		$	—			6		$	9		$	(2	)		7		$	1		$	(1	)		—		$	5		$	(2	)		3
Income from discontinued operations(4)		(1	)		—			(1	)		(1	)		—			(1	)
Fair value adjustments to Venator investment		2			—			2			19			—			19
(Income) loss from discontinued operations(4)																				(9	)		10			1			(19	)		13			(6	)
Fair value adjustments to Venator investment, net																				7			—			7			3			—			3
Certain legal and other settlements and related expenses		12			(4	)		8			2			(1	)		1			1			(1	)		—			—			—			—
Costs associated with the Albemarle Settlement, net		1			—			1			—			—			—			1			(1	)		—			—			—			—
Loss on sale of business/assets		4			(1	)		3			—			—			—
Loss on sale of businesses/assets																				16			(4	)		12			—			—			—
Income from transition services arrangements		(1	)		—			(1	)		(1	)		—			(1	)		—			—			—			(2	)		—			(2	)
Certain nonrecurring information technology project implementation costs		2			—			2			1			—			1			1			—			1			2			—			2
Amortization of pension and postretirement actuarial losses		14			(3	)		11			22			(5	)		17			10			(2	)		8			19			(4	)		15
Plant incident remediation costs		—			—			—			4			(1	)		3			1			—			1			2			—			2
Restructuring, impairment and plant closing and transition costs(2)		3			(1	)		2			24			(6	)		18			14			(3	)		11			—			—			—
Adjusted net income(1)							$	256								$	147								$	141								$	226

Weighted average shares-basic								212.7									220.4									197.7									219.4
Weighted average shares-diluted								215.4									222.6									199.2									221.3

Basic net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	1.04								$	0.38								$	0.52								$	0.93
Income from discontinued operations								0.01									—									(0.01	)								0.02
Net income							$	1.05								$	0.38								$	0.51								$	0.95

Diluted net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	1.03								$	0.37								$	0.51								$	0.92
Income from discontinued operations								0.01									—									(0.01	)								0.02
Net income							$	1.04								$	0.37								$	0.50								$	0.94

Other non-GAAP measures:
Diluted adjusted net income per share(1)							$	1.19								$	0.66								$	0.71								$	1.02

Net cash provided by (used in) operating activities from continuing operations							$	85								$	(16	)
Capital expenditures from continuing operations								(69	)								(98	)
Free cash flow from continuing operations(1)							$	16								$	(114	)

Effective tax rate								21	%								26	%
Impact of non-GAAP adjustments(5)								—									(3	)%
Adjusted effective tax rate								21	%								23	%

Table of Contents

	Nine months									Nine months
	ended									ended
	September 30, 2022									September 30, 2021
				Tax and									Tax and
	Gross			other(3)			Net			Gross			other(3)			Net
Reconciliation of net income to adjusted net income
Net income							$	597								$	497
Net income attributable to noncontrolling interests								(46	)								(49	)
Business acquisition and integration expenses and purchase accounting inventory adjustments	$	11		$	(3	)		8		$	19		$	(4	)		15
Income from discontinued operations(4)		(55	)		25			(30	)		(68	)		32			(36	)
Fair value adjustments to Venator investment, net		9			—			9			28			—			28
Loss on early extinguishment of debt		—			—			—			27			(6	)		21
Certain legal and other settlements and related expenses		15			(4	)		11			10			(3	)		7
Costs associated with the Albemarle Settlement, net		3			(1	)		2			—			—			—
Loss (gain) on sale of businesses/assets		27			(6	)		21			(30	)		4			(26	)
Income from transition services arrangements		(2	)		—			(2	)		(6	)		1			(5	)
Certain nonrecurring information technology project implementation costs		4			(1	)		3			6			(1	)		5
Amortization of pension and postretirement actuarial losses		32			(7	)		25			56			(13	)		43
Plant incident remediation (credits) costs		(4	)		1			(3	)		3			—			3
Restructuring, impairment and plant closing and transition costs(2)		44			(11	)		33			36			(8	)		28
Adjusted net income(1)							$	628								$	531

Weighted average shares-basic								205.2									220.2
Weighted average shares-diluted								207.2									222.2

Basic net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	2.54								$	1.87
Income from discontinued operations								0.15									0.16
Net income							$	2.69								$	2.03

Diluted net income attributable to Huntsman Corporation per share:
Income from continuing operations							$	2.52								$	1.86
Income from discontinued operations								0.14									0.16
Net income							$	2.66								$	2.02

Other non-GAAP measures:
Diluted adjusted net income per share(1)							$	3.03								$	2.39

Net cash provided by operating activities from continuing operations							$	595								$	182
Capital expenditures from continuing operations								(186	)								(241	)
Free cash flow from continuing operations(1)							$	409								$	(59	)

Effective tax rate								21	%								18	%
Impact of non-GAAP adjustments(5)								1	%								—
Adjusted effective tax rate(1)								22	%								18	%

Other cash flow measures:
Taxes paid on sale of business(6)							$	—								$	(3	)
Cash received from the Albemarle Settlement, net(7)								78									—

NM—Not meaningful

(1)	See “—Non-GAAP Financial Measures.”

(2)	Includes costs associated with transition activities ~~relating~~related primarily to our Corporate program to optimize our global approach to leverage shared services capabilities.

(3)	The income tax impacts, if any, are computed on the pre-tax adjustments using a with and without approach.

(4)	In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense.

(5)	For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income to adjusted net income noted above.

(6)

Represents the taxes paid in the second quarter of 2021 in connection with the earnout provision achieved under the terms of the sales agreement of the India-based DIY business. For more information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business” to our condensed consolidated financial statements.

(7)	Represents cash received of $332.5 million, net of legal fees and cash taxes paid of approximately $255 million.

3741

Table of Contents

Non-GAAP Financial Measures

Our condensed consolidated financial statements are prepared in accordance with GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in their entirety and not to rely on any single financial measure. These non-GAAP measures exclude the impact of certain income and expenses that we do not believe are indicative of our core operating results.

Adjusted EBITDA

Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator ~~investment;~~investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; ~~(e)~~(f) costs associated with the Albemarle Settlement, net; ~~(f)~~(g) loss (gain) on sale of business/assets; ~~(g)~~(h) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(h)~~(i) certain nonrecurring information technology project implementation costs; ~~(i)~~(j) amortization of pension and postretirement actuarial losses; ~~(j)~~(k) plant incident remediation (credits) costs; and ~~(k)~~(l) restructuring, impairment and plant closing and transition costs. We believe that net income of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA.

We believe adjusted EBITDA is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income of Huntsman Corporation or Huntsman International, as appropriate, or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company’s capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies.

Nevertheless, our management recognizes that there are material limitations associated with the use of adjusted EBITDA in the evaluation of our Company as compared to net income of Huntsman Corporation or Huntsman International, as appropriate, which reflects overall financial performance. For example, we have borrowed money in order to finance our operations and interest expense is a necessary element of our costs and ability to generate revenue. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone.

3842

Table of Contents

Adjusted Net Income

Adjusted net income is computed by eliminating the after-tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) income from discontinued operations; (c) fair value adjustments to Venator ~~investment;~~investment, net; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; ~~(e)~~(f) costs associated with the Albemarle Settlement, net; ~~(f) loss~~(g) gain on sale of business/assets; ~~(g)~~(h) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(h)~~(i) certain nonrecurring information technology project implementation costs; ~~(i)~~(j) amortization of pension and postretirement actuarial losses; ~~(j)~~(k) plant incident remediation (credits) costs; and ~~(k)~~(l) restructuring, impairment and plant closing and transition costs. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. Adjusted net income and adjusted net income per share amounts are presented solely as supplemental information.

We believe adjusted net income is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

Free Cash Flow

We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt.

Adjusted Effective Tax Rate

We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted, that we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

Our forward-looking adjusted effective tax rate is calculated based on our forecast effective tax rate, and the range of our forward-looking adjusted effective tax rate equals the range of our forecast effective tax rate. We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted effective tax rate represents the forecast effective tax rate on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our effective tax rate to differ.

3943

Table of Contents

Three Months Ended ~~March 31,~~September 30, 2022 Compared with Three Months Ended ~~March 31,~~September 30, 2021

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For the three months ended ~~March 31,~~September 30, 2022, income from continuing operations attributable to Huntsman Corporation was ~~$222~~$101 million, ~~an increase~~a decrease of ~~$140~~$102 million from ~~$82~~$203 million in the 2021 period. For the three months ended ~~March 31,~~September 30, 2022, income from continuing operations attributable to Huntsman International was ~~$225~~$100 million, ~~an increase~~a decrease of ~~$141~~$103 million from ~~$84~~$203 million in the 2021 period. The ~~increases~~decreases noted above were the result of the following items:

●

Revenues for the three months ended ~~March 31,~~September 30, 2022 ~~increased~~decreased by ~~$552~~$86 million, or ~~30%~~4%, as compared with the 2021 period. The ~~increase~~decrease was primarily due to lower sales volumes in all our segments, partially offset by higher average selling prices in all our ~~segments as well as higher sales volumes in our Polyurethanes and Performance Products~~ segments. See “—Segment Analysis” below.

●

Gross profit for the three months ended ~~March 31,~~September 30, 2022 ~~increased~~decreased by ~~$173~~$88 million, or ~~44%~~20%, as compared with the 2021 period. The ~~increase~~decrease resulted primarily from ~~higher~~lower gross profits in ~~all~~ our ~~segments.~~Polyurethanes segment. See “—Segment Analysis” below.

●

~~Operating~~Our operating expenses, net and the operating expenses, net of Huntsman International for the three months ended ~~March 31,~~September 30, 2022 ~~increased~~decreased by ~~$19~~$9 million and $7 million, respectively, or 8%4% and 3%, respectively, as compared with the 2021 period, primarily related to ~~an increase~~a decrease in selling, general and administrative expenses.

●

~~For the three months ended March 31, 2022, restructuring,~~Restructuring, impairment and plant closing costs were ~~nil~~$12 million for the three months ended September 30, 2022 as compared with ~~costs~~a credit of ~~$24~~$1 million in the 2021 period. For further information, ~~concerning restructuring activities,~~ see “Note 7. Restructuring, Impairment and Plant Closing Costs” to our condensed consolidated financial statements.

●

Interest expense, net for the three months ended March 31, 2022 decreased by $5 million, or 26%, as compared with the 2021 period, primarily related to the redemption in full of our 2021 Senior Notes in the first half of 2021.

●

Equity in income of investment in unconsolidated affiliates for the three months ended ~~March 31,~~September 30, 2022 decreased to ~~$15~~$21 million from ~~$38~~$34 million in the 2021 period, primarily related to a decrease in income at our PO/MTBE joint venture in China, in which we hold a 49% interest.

●

~~For the three months ended March 31, 2022, we recorded a net loss of $2 million in fair~~Fair value adjustments to our investment in Venator and the related option to sell our remaining Venator shares, net was a net loss of $7 million for the three months ended September 30, 2022 as compared with a net loss of ~~$19~~$3 million in the 2021 period. For further information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest” to our condensed consolidated financial statements.

●

Our income tax expense for the three months ended ~~March 31,~~September 30, 2022 ~~increased~~decreased to ~~$65~~$30 million from $34 million in the 2021 period. The income tax expense of Huntsman International for the three months ended ~~March 31,~~September 30, 2022 decreased to $30 million from $35 million in the 2021 period. The decrease in income tax expense was primarily due to the decrease in pretax income, exclusive of the fair value adjustments to our investment in Venator. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. For further information, see “Note 18. Income Taxes” to our condensed consolidated financial statements.

Table of Contents

	Three months						Percent
	ended						change
	September 30,						favorable
(Dollars in millions)	2022			2021			(unfavorable)
Revenues
Polyurethanes	$	1,257		$	1,403			(10	)%
Performance Products		434			399			9	%
Advanced Materials		328			304			8	%
Total reportable segments’ revenue		2,019			2,106			(4	)%
Intersegment eliminations		(8	)		(9	)		NM
Total	$	2,011		$	2,097			(4	)%

Huntsman Corporation
Segment adjusted EBITDA(1)
Polyurethanes	$	138		$	246			(44	)%
Performance Products		110			103			7	%
Advanced Materials		58			48			21	%
Total reportable segments’ adjusted EBITDA		306			397			(23	)%
Corporate and other		(35	)		(48	)		27	%
Total	$	271		$	349			(22	)%

Huntsman International
Segment adjusted EBITDA(1)
Polyurethanes	$	138		$	246			(44	)%
Performance Products		110			103			7	%
Advanced Materials		58			48			21	%
Total reportable segments’ adjusted EBITDA		306			397			(23	)%
Corporate and other		(36	)		(47	)		23	%
Total	$	270		$	350			(23	)%

NM—Not meaningful

(1)

For further information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 20. Operating Segment Information” to our condensed consolidated financial statements.

	Three months ended September 30, 2022 vs 2021
	Average selling price(1)
	Local			Foreign currency			Mix &			Sales
	currency			translation impact			other			volumes(2)
Period-over-period increase (decrease)
Polyurethanes		12	%		(5	)%		(1	)%		(16	)%
Performance Products		23	%		(4	)%		3	%		(13	)%
Advanced Materials		16	%		(7	)%		15	%		(16	)%

	Three months ended September 30, 2022 vs June 30, 2022
	Average selling price(1)
	Local			Foreign currency			Mix &			Sales
	currency			translation impact			other			volumes(2)
Period-over-period increase (decrease)
Polyurethanes		(1	)%		(2	)%		—			(4	)%
Performance Products		(1	)%		(1	)%		1	%		(11	)%
Advanced Materials		2	%		(3	)%		2	%		(3	)%

(1)	Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)	Excludes sales volumes of byproducts and raw materials.

Table of Contents

Polyurethanes

The decrease in revenues in our Polyurethanes segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to lower sales volumes and the negative impact of weaker major international currencies against the U.S. dollar, partially offset by higher MDI average selling prices. Sales volumes decreased primarily due to lower demand, particularly in our European and construction markets. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins in Europe and Asia, the negative impact of weaker major international currencies against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China, partially offset by higher MDI margins in the Americas and lower fixed costs.

Performance Products

The increase in revenues in our Performance Products segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes. Average selling prices increased primarily due to commercial excellence programs and in response to an increase in raw material costs. Sales volumes decreased primarily due to a shift in business strategy as well as lower demand, particularly in Europe. The increase in segment adjusted EBITDA was primarily due to increased revenues and margins, partially offset by higher costs.

Advanced Materials

The increase in revenues in our Advanced Materials segment for the three months ended September 30, 2022 compared to the same period of 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes. Average selling prices increased largely in response to higher raw material, energy and logistics costs as well as improved sales mix. Sales volumes decreased primarily due to deselection of lower margin business. The increase in segment adjusted EBITDA was primarily due to higher sales prices and improved sales mix.

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman Corporation was a loss of $35 million as compared to a loss of $48 million for the same period of 2021. For the three months ended September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman International was a loss of $36 million as compared to a loss of $47 million for the same period of 2021. The increase in adjusted EBITDA from Corporate and other resulted primarily from an increase in unallocated foreign currency exchange gains and a decrease in corporate overhead costs and LIFO valuation losses.

Table of Contents

Nine Months Ended September 30, 2022 Compared with Nine Months Ended September 30, 2021

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For the nine months ended September 30, 2022, income from continuing operations attributable to Huntsman Corporation was $521 million, an increase of $109 million from $412 million in the 2021 period. For the nine months ended September 30, 2022, income from continuing operations attributable to Huntsman International was $524 million, an increase of $109 million from $415 million in the 2021 period. The increases noted above were the result of the following items:

●

Revenues for the nine months ended September 30, 2022 increased by $815 million, or 15%, as compared with the 2021 period. The increase was primarily due to higher average selling prices in all our segments, partially offset by lower sales volumes in all our segments. See “—Segment Analysis” below.

●

Gross profit for the nine months ended September 30, 2022 increased by $195 million, or 17%, as compared with the 2021 period. The increase resulted primarily from higher gross profits in our Performance Products and Advanced Materials segments. See “—Segment Analysis” below.

●

Our operating expenses, net and the operating expenses, net of Huntsman International for the nine months ended September 30, 2022 increased by $24 million and $26 million, respectively, or 4% for both, as compared with the 2021 period, primarily related to the gain on sale of the India-based DIY business pursuant to an earnout provision in the second quarter of 2021 and an increase in legal expenses and selling, general and administrative expenses.

●

Interest expense, net for the nine months ended September 30, 2022 decreased by $6 million, or 12%, as compared with the 2021 period, primarily related to the redemption in full of our 2022 Senior Notes in the first half of 2021. For further information, see “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

Equity in income of investment in unconsolidated affiliates for the nine months ended September 30, 2022 decreased to $55 million from $118 million in the 2021 period, primarily related to a decrease in income at our PO/MTBE joint venture in China, in which we hold a 49% interest.

●

Fair value adjustments to our investment in Venator and the related option to sell our remaining Venator shares, net was a net loss of $9 million for the nine months ended September 30, 2022 as compared with a net loss of $28 million in the 2021 period. For further information, see “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest” to our condensed consolidated financial statements.

●

Loss on early extinguishment of debt was nil for the nine months ended September 30, 2022 as compared with $27 million in the 2021 period, primarily due to the full redemption of our 2022 Senior Notes in the second quarter of 2021. For further information, see “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

●

Our income tax expense for the nine months ended September 30, 2022 increased to ~~$65~~$155 million from ~~$35~~$101 million in the 2021 period. The income tax expense of Huntsman International for the nine months ended September 30, 2022 increased to $156 million from $102 million in the 2021 period. The increase in income tax expense was primarily due to the increase in pretax income, exclusive of the fair value adjustments to our investment in Venator. Our income tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. For further information, ~~concerning income taxes,~~ see “Note 18. Income Taxes” to our condensed consolidated financial statements.

4047

Table of Contents

	Three months						Percent			Nine months						Percent
	ended						change			ended						Change
	March 31,						favorable			September 30,						Favorable
(Dollars in millions)	2022			2021			(unfavorable)
										2022			2021			(Unfavorable)
Revenues
Polyurethanes	$	1,386		$	1,068			30	%	$	3,996		$	3,626			10	%
Performance Products		480			305			57	%		1,406			1,075			31	%
Advanced Materials		335			278			21	%		999			881			13	%
Textile Effects		197			193			2	%
Total reportable segment’s revenue		2,398			1,844			30	%
Total reportable segments’ revenue											6,401			5,582			15	%
Intersegment eliminations		(9	)		(7	)		NM			(28	)		(24	)		NM
Total	$	2,389		$	1,837			30	%	$	6,373		$	5,558			15	%

Huntsman Corporation
Segment adjusted EBITDA(1)
Polyurethanes	$	224		$	207			8	%	$	591		$	661			(11	)%
Performance Products		146			63			132	%		408			254			61	%
Advanced Materials		67			44			52	%		192			150			28	%
Textile Effects		28			25			12	%
Total reportable segments’ adjusted EBITDA		465			339			37	%		1,191			1,065			12	%
Corporate and other		(50	)		(50	)		—			(123	)		(146	)		16	%
Total	$	415		$	289			44	%	$	1,068		$	919			16	%

Huntsman International
Segment adjusted EBITDA(1)
Polyurethanes	$	224		$	207			8	%	$	591		$	661			(11	)%
Performance Products		146			63			132	%		408			254			61	%
Advanced Materials		67			44			52	%		192			150			28	%
Textile Effects		28			25			12	%
Total reportable segments’ adjusted EBITDA		465			339			37	%		1,191			1,065			12	%
Corporate and other		(47	)		(47	)		—			(119	)		(140	)		15	%
Total	$	418		$	292			43	%	$	1,072		$	925			16	%

NM—Not meaningful

(1)

Three months ended March 31, 2022 vs 2021

Average selling price(1)

Local

Foreign currency

Mix &

Sales

currency

translation impact

other

volumes(2)

Period-over-period increase (decrease)

Polyurethanes
29 % (3 )% — 4 %
Performance Products
49 % (3 )% 8 % 3 %
Advanced Materials
34 % (4 )% 8 % (17 )%
Textile Effects
16 % (2 )% (1 )% (11 )%

	Three months ended March 31, 2022 vs December 31, 2021												Nine months ended September 30, 2022 vs September 30, 2021
	Average selling price(1)												Average Selling Price(1)
	Local			Foreign currency			Mix &			Sales			Local			Foreign Currency			Mix &			Sales
	currency			translation impact			other			volumes(2)			Currency			Translation Impact			Other			Volumes(2)
Period-over-period increase (decrease)
Period-Over-Period (Decrease) Increase
Polyurethanes		7	%		(1	)%		—			(7	)%		21	%		(4	)%		(1	)%		(6	)%
Performance Products		11	%		(1	)%		2	%		5	%		34	%		(3	)%		4	%		(4	)%
Advanced Materials		6	%		(1	)%		7	%		(6	)%		19	%		(5	)%		16	%		(17	)%
Textile Effects		2	%		—			(3	)%		2	%

(1)	Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)	Excludes sales volumes of byproducts and raw materials.

4148

Table of Contents

Polyurethanes

The increase in revenues in our Polyurethanes segment for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 compared to the same period of 2021 was ~~largely~~primarily due to higher MDI average selling prices, partially offset by lower sales volumes and ~~slightly higher sales volumes. MDI average selling prices increased in all our regions.~~the negative impact of weaker major international currencies against the U.S. dollar. Sales volumes ~~increased~~decreased primarily due to ~~stronger~~lower demand, particularly in ~~all~~ our ~~regions.~~European and construction markets. The ~~increase~~decrease in segment adjusted EBITDA was primarily due to ~~higher MDI margins resulting~~lower equity earnings from ~~higher MDI pricing~~our minority-owned joint venture in China, lower sales volumes and ~~slightly higher sales volumes,~~the negative impact of weaker major international currencies against the U.S. dollar, partially offset by higher ~~raw material costs~~margins and lower ~~earnings from our PO/MTBE joint venture in China.~~ fixed costs.

Performance Products

The increase in revenues in our Performance Products segment for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 compared to the same period of 2021 was primarily due to higher average selling prices, ~~and slightly higher~~partially offset by lower sales volumes. Average selling prices increased primarily due to ~~stronger demand in relation to the ongoing recovery from the global economic slowdown as well as~~commercial excellence programs and in response to an increase in raw material costs. Sales volumes ~~increased~~decreased primarily due to ~~stronger demand~~a shift in business strategy as well as ~~favorable product mix changes aligned with our value-over-volume business strategy.~~lower demand, particularly in Europe. The increase in segment adjusted EBITDA was primarily due to increased revenues and margins, partially offset by ~~increased fixed~~higher costs.

Advanced Materials

The increase in revenues in our Advanced Materials segment for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 compared to the same period inof 2021 was primarily due to higher average selling prices, partially offset by lower sales volumes. Average selling prices increased ~~across all markets~~ largely in response to higher raw material, energy and logistics ~~costs.~~costs as well as improved sales mix. Sales volumes decreased primarily due to deselection of lower margin ~~base resins~~ business. The increase in segment adjusted EBITDA was primarily due to higher sales prices and ~~the benefit from the Gabriel Acquisition.~~

~~Textile Effects~~

The increase in revenues in our Textile Effects segment for the three months ended March 31, 2022 compared to the same period of 2021 was due to higher average selling prices, partially offset by a decrease inimproved sales volumes. Average selling prices increased in response to higher direct costs. Sales volumes decreased primarily due to a deselection of certain volume as well as lower demand. The increase in segment adjusted EBITDA was primarily due to improved portfolio mix.

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the ~~three~~nine months ended ~~March 31,~~September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman Corporation ~~remained unchanged at~~was a loss of ~~$50~~$123 million as compared to a loss of $146 million for the same period of 2021. For the ~~three~~nine months ended ~~March 31,~~September 30, 2022, adjusted EBITDA from Corporate and other for Huntsman International ~~remained unchanged at~~was a loss of ~~$47~~$119 million as compared to a loss of $140 million for the same period of 2021. The increase in adjusted EBITDA from Corporate and other resulted primarily from an increase in unallocated foreign currency exchange gains and a decrease in corporate overhead costs and LIFO valuation losses.

4249

Table of Contents

Liquidity and Capital Resources

The following is a discussion of our liquidity and capital resources and does not include separate information with respect to Huntsman International in accordance with General Instructions H(1)(a) and (b) of Form 10-Q.

Cash Flows for the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2022 Compared with the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2021

Net cash provided by ~~(used in)~~ operating activities from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was ~~$85~~$595 million and ~~$(16)~~$182 million, respectively. The increase in net cash provided by operating activities from continuing operations during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 compared with the same period in 2021 was primarily attributable to increased operating income as described in “—Results of Operations” above for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 as compared with the same period of 2021 ~~partially offset by~~as well as a net cash ~~outflow~~inflow of ~~$47~~$143 million related to changes in operating assets and liabilities.

Net cash used in investing activities from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was ~~$65~~$176 million and ~~$323~~$430 million, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, we paid ~~$69~~$186 million and ~~$98~~$241 million for capital expenditures, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, we received $43 million for the sale of businesses, primarily due to the receipt of $28 million pursuant to an earnout provision in connection with the sale of the India-based DIY business, and we paid $245 million for the acquisition of businesses, primarily related to approximately ~~$240~~$242 million paid for the Gabriel Acquisition, net of cash acquired.

Net cash used in financing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was ~~$252~~$905 million and ~~$579~~$809 million, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, we ~~repurchased $203~~paid $755 million and $102 million for repurchases of our common ~~stock.~~stock, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, we redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 2021 Senior Notes, and we redeemed in full $400 million in aggregate principal amount of our 2022 Senior Notes. Additionally, during the nine months ended September 30, 2021, we issued $400 million in aggregate principal amount of our 2031 Senior Notes and received borrowings of approximately 104 million SAR (approximately $27 million) related to funding on a new term loan facility of our consolidated 50%-owned joint venture, AAC. See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements.

Free cash flow from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021 was a source of cash of ~~$16~~$409 million and a use of cash of ~~$114~~$59 million, respectively. The increase in free cash flow was primarily attributable to the increase in cash provided by operating activities from continuing operations as well as a decrease in cash used for capital expenditures during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 as compared with the same period in 2021.

Table of Contents

Changes in Financial Condition

The following information summarizes our working capital position (dollars in millions):

March 31,

December 31,

(Decrease)

Percent

2022

2021

Increase

Change

Cash and cash equivalents
$ 807 $ 1,041 $ (234 ) (22 )%
Accounts and notes receivable, net
1,310 1,186 124 10 %
Inventories
1,382 1,201 181 15 %
Receivable associated with the Albemarle Settlement
333 333 — —
Other current assets
156 167 (11 ) (7 )%
Total current assets
3,988 3,928 60 2 %

Accounts payable
1,315 1,208 107 9 %
Accrued liabilities
732 780 (48 ) (6 )%
Current portion of debt
21 12 9 75 %
Current operating lease liabilities
50 51 (1 ) (2 )%
Total current liabilities
2,118 2,051 67 3 %
Working capital
$ 1,870 $ 1,877 $ (7 ) —

	September 30,		December 31,		(Decrease)			Percent
	2022		2021		Increase			Change
Cash and cash equivalents	$	515	$	1,041	$	(526	)		(51	)%
Accounts and notes receivable, net		1,004		1,015		(11	)		(1	)%
Inventories		1,079		1,038		41			4	%
Receivable associated with the Albemarle Settlement		—		333		(333	)		(100	)%
Other current assets		115		155		(40	)		(26	)%
Current assets held for sale(1)		483		346		137			40	%
Total current assets		3,196		3,928		(732	)		(19	)%

Accounts payable		898		1,114		(216	)		(19	)%
Accrued liabilities		393		713		(320	)		(45	)%
Current portion of debt		12		12		—			—
Current operating lease liabilities		50		49		1			2	%
Current liabilities held for sale(1)		242		163		79			48	%
Total current liabilities		1,595		2,051		(456	)		(22	)%
Working capital	$	1,601	$	1,877	$	(276	)		(15	)%

(1)

Total assets and liabilities held for sale as of September 30, 2022 are classified as current because it is probable that the sale of our Textile Effects Business will close within a year. For more information see “Note 4. Discontinued Operations and Business Dispositions—Sale of Textile Effects Business” to our condensed consolidated financial statements.

Our working capital decreased by $7$276 million as a result of the net impact of the following significant changes:

●

The decrease in cash and cash equivalents of ~~$234~~$526 million resulted from the matters identified on our condensed consolidated statements of cash flows. See also “—Cash Flows for the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2022 Compared with the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2021.”

●

~~Accounts receivable~~Inventories increased by ~~$124~~$41 million primarily due to higher ~~revenues~~inventory costs.

●

Receivable associated with the arbitration award we won on October 28, 2021 in excess of $600 million against Albemarle Corporation (“Albemarle”) for fraud and breach of contract (the “Albemarle Settlement”) decreased to nil due to the ~~first~~receipt of the final arbitration award payment of $332.5 million during the second quarter of ~~2022 compared~~2022.

●

Other current assets decreased by $40 million primarily due to ~~the fourth quarter~~amortization of ~~2021.~~

deferred charges related to insurance premiums.

●

~~Inventories increased~~Accounts payable decreased by ~~$181~~$216 million primarily due to ~~higher inventory costs~~a decrease in non-trade payables related to insurance premiums and ~~volumes.~~

●

~~Accounts payable increased by $107 million primarily due to higher inventory purchases.~~a reduction of capital accruals.

●

Accrued liabilities decreased by ~~$48~~$320 million primarily related to the payment of legal fees and cash taxes associated with the Albemarle Settlement and a decrease in accrued ~~rebates, higher accrued~~ compensation costs and current income taxes payable.

●

~~Current portion of debt increased by $9 million primarily due to a borrowing at AAC.~~

4351

Table of Contents

Direct and Subsidiary Debt

See “Note 8. Debt—Direct and Subsidiary Debt” to our condensed consolidated financial statements.

Debt Issuance Costs

See “Note 8. Debt—Direct and Subsidiary Debt—Debt Issuance Costs” to our condensed consolidated financial statements.

Revolving Credit Facility

See “Note 8. Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

A/R Programs

See “Note 8. Debt—Direct and Subsidiary Debt—A/R Programs” to our condensed consolidated financial statements.

Senior Notes

See “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

Variable Interest Entity Debt

See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements.

Compliance with Covenants

See “Note 8. Debt—Compliance with Covenants” to our condensed consolidated financial statements.

4452

Table of Contents

We depend upon our cash, Revolving Credit Facility, A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs. As of ~~March 31,~~September 30, 2022, we had ~~$2,257~~$1,946 million of combined cash and unused borrowing capacity, consisting of ~~$807~~$515 million in cash, ~~$253~~$1,189 million in availability under our Revolving Credit Facility and ~~$1,197~~$242 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors. The following matters are expected to have a significant impact on our liquidity:

Short-Term Liquidity

●

Cash invested in our accounts receivable and inventory, net of accounts payable, was approximately ~~$201~~$301 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2022, as reflected in our condensed consolidated statements of cash flows. We expect volatility in our working capital components to continue.

●

During 2022, we expect to spend approximately ~~$300~~$280 million on capital expenditures. Our future expenditures include certain environmental, health and safety maintenance and upgrades; periodic maintenance and repairs applicable to major units of manufacturing facilities; expansions of our existing facilities; certain cost reduction projects; and certain information technology expenditures. We expect to fund capital expenditures with cash provided by operations.

●

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, we made contributions to our pension and other postretirement benefit plans related to continuing operations of ~~$13~~$35 million. During 2022, we expect to contribute an additional amount of approximately ~~$36~~$10 million to these plans.

●

On October 26, 2021, our Board of Directors approved a new share repurchase program of $1 billion. In conjunction with the inception of this plan, we retired our prior share repurchase program. On March 25, 2022 our Board of Directors increased the authorization of our existing share repurchase program from $1 billion to $2 billion.

During the ~~first quarter of~~nine months ended September 30, 2022, we repurchased ~~5,549,348~~22,853,686 shares of our common stock for approximately ~~$210~~$752 million, excluding commissions, under ~~this~~our share repurchase program. From ~~April~~October 1, 2022 through ~~April 20,~~October 25, 2022, we repurchased an additional ~~906,000~~1,539,537 shares of our common stock for approximately ~~$32~~$40 million, excluding commissions.

●

On October 28, 2021, we won an arbitration award in excess of $600 million against ~~Albemarle Corporation (“Albemarle”) for fraud and breach of contract (“Albemarle Settlement”).~~Albemarle. On November 4, 2021, Albemarle agreed to waive any appeal and pay $665 million, of which we received $332.5 million on December 2, 2021 and ~~expect to receive~~received a final payment of $332.5 million ~~by early~~on May 2, 2022. We ~~expect to pay estimated~~paid legal fees and cash taxes of approximately $255 million in the second quarter of 2022.

●

Long-Term Liquidity

●

During 2020, management implemented cost realignment and synergy plans. In connection with these plans, we remain committed to achieving annualized cost savings and synergy benefits of approximately $140 million during 2023, as previously communicated. Associated with these plans, we expect net cash restructuring and integration costs, including capital expenditures, of approximately $115 million, of which we have spent approximately ~~$88~~$102 million to date.

●

During 2021, management announced additional cost realignment plans. In connection with these plans, we currently expect to achieve annualized cost savings of approximately $100 million by the end of 2023. Associated with these plans, we expect net cash restructuring and integration costs, including capital expenditures, of approximately $135 million through 2024, of which we have spent approximately $25 million to date.

●

On February 14, 2022, our Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend. We

●

On April 29, 2022, a New Orleans jury awarded us approximately $94 million in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site. The case was filed after Praxair refused to properly maintain its own Geismar facility and then repeatedly failed to supply our requirements for industrial gas needed to manufacture MDI under long-term supply contracts that expired in 2013. After the court applies the appropriate amount of interest, we expect that total damages awarded to ~~distribute~~us will exceed $125 million. The award is subject to appeal, and as such, we have not yet recognized the award in our condensed consolidated statements of operations.

●

On May 20, 2022, Huntsman International entered into the 2022 Revolving Credit Facility. Borrowings will bear interest at the rates specified in the credit agreement governing the 2022 Credit Facility, which will vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the credit agreement will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional ~~$5.3~~$500 million, ~~in dividends each quarter related~~subject to ~~this dividend increase.~~the satisfaction of certain conditions. In connection with entering into the 2022 Revolving Credit Facility, Huntsman International terminated all commitments and repaid all obligations under its 2018 $1.2 billion senior unsecured credit facility. See “Note 8. Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

As of ~~March 31,~~September 30, 2022, we had ~~$21~~$12 million classified as current portion of debt, including debt at our variable interest entities of ~~$17~~$10 million and certain other short-term facilities and scheduled amortization payments totaling $4$2 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.

As of ~~March 31,~~September 30, 2022, we had approximately ~~$506~~$462 million of cash and cash equivalents held by our foreign subsidiaries, including our variable interest entities. We intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate cash as dividends, which dividends would generally not be subject to U.S. taxation as a result of the U.S. Tax Reform Act. However, such repatriation may potentially be subject to certain foreign withholding taxes.

4553

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of ~~March 31,~~September 30, 2022. Based on this evaluation, our chief executive officer and chief financial officer have concluded that, as of ~~March 31,~~September 30, 2022, our disclosure controls and procedures were effective, in that they ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

No changes to our internal control over financial reporting occurred during the quarter ended ~~March 31,~~September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). However, we can only give reasonable assurance that our internal controls over financial reporting will prevent or detect material misstatements on a timely basis. ~~Ineffective internal controls over financial reporting could cause investors to lose confidence in our reported financial information and could result in a lower trading price for our securities.~~

4654

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There have been no material developments with respect to the legal proceedings referenced in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021. In addition to the risk factors noted in the Annual Report on Form 10-K, the following risk factor is applicable to us.

The proposed sale of our Textile Effects Business is contingent upon the satisfaction of a number of conditions, will require significant time and attention of our management and may have an adverse effect on us if not completed.

On August 9, 2022, we entered into a definitive agreement to sell our Textile Effects Business to Archroma for a total enterprise value of $718 million, which includes the assumption of approximately $125 million in net underfunded pension liabilities as of December 31, 2021. Completion of the proposed sale is subject to the satisfaction of various closing conditions, including but not limited to regulatory approvals. There can be no assurance that any of such conditions will be satisfied and that the proposed sale will be successfully completed. These or other unanticipated developments could delay or prevent the transaction from closing or cause it to occur on terms or conditions that are less favorable than anticipated, which could cause our common stock to experience negative reactions from the financial markets.

In pursuing the proposed sale, our ongoing businesses may be adversely affected, and we may be subject to certain risks and consequences, including, but not limited to, the following:

• execution of the proposed sale has required, and will continue to require, significant time and attention from management, which may postpone the execution of other initiatives that may have been beneficial to us;

• completion of the proposed sale will require strategic, structural and process realignment and restructuring actions within our operations, which could lead to a disruption of our operations, as well as the loss of, or inability to recruit, key personnel needed to operate and grow our businesses;

• completion of the proposed sale may require certain management and procedural redundancies as we prepare for closing, which may result in operating inefficiencies; and

• whether or not the proposed sale is completed, we may be responsible for certain costs and expenses, such as legal, accounting and other professional fees, which may be significant.

Any of these factors could have a material adverse effect on our financial condition, results of operations, cash flows and the price of our common stock.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information with respect to shares of our common stock that we repurchased as part of our share repurchase program and shares of restricted stock granted under our stock incentive plans that we withheld upon vesting to satisfy our tax withholding obligations during the three months ended ~~March 31,~~September 30, 2022.

Total number of

Approximate dollar

shares purchased

value of shares that

Total number

Average

as part of publicly

may yet be purchased

of shares

price paid

announced plans

under the plans or

purchased

per share(1)

or programs(2)

programs(2)

January 1 - January 31
851,000 $ 36.16 851,000 $ 868,000,000
February 1 - February 28
2,035,743 38.93 1,788,301 798,000,000
March 1 - March 31
2,910,365 37.50 2,910,047 1,689,000,000
Total
5,797,108 37.81 5,549,348

					Total number of		Approximate dollar
					shares purchased		value of shares that
	Total number		Average		as part of publicly		may yet be purchased
	of shares		price paid		announced plans		under the plans or
	purchased		per share(1)		or programs(2)		programs(2)
July 1 - July 31		1,944,359	$	28.86		1,943,177	$	1,342,000,000
August 1 - August 31		3,815,850		29.37		3,814,930		1,230,000,000
September 1 - September 30		3,175,239		26.16		3,174,808		1,147,000,000
Total		8,935,448		28.12		8,932,915

(1)

Represents net purchase price per share, exclusive of any fees or commissions.

(2)

On October 26, 2021, our Board of Directors approved a new share repurchase program of $1 billion. In conjunction with the inception of this program, we retired our prior share repurchase program. On March 25, 2022, our Board of Directors increased the authorization of our existing share prepurchase program from $1 billion of repurchases to $2 billion. Similar to our prior share repurchase program, the share repurchase program will be supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the ~~first~~third quarter of 2022, we repurchased ~~5,549,348~~8,932,915 shares of our common stock for approximately ~~$210~~$251 million, excluding commissions.

4755

Table of Contents

ITEM 6. EXHIBITS

See the Exhibit Index at the end of this Quarterly Report on Form 10-Q for exhibits filed with this report.

4856

Table of Contents

EXHIBIT INDEX

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	Exhibit	Filing Date
2.1	*	Equity and Asset Purchase Agreement, dated as of August 9, 2022, by and among Huntsman, Archroma, Archroma Germany and solely for purposes set forth in the Purchase Agreement, the Archroma Financing Party.	8-K	2.1	August 9, 2022
31.1	**	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	**	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	**	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	**	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	**	Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	**	Inline XBRL Taxonomy Extension Schema
101.CAL	**	Inline XBRL Taxonomy Extension Calculation Linkbase
101.LAB	**	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	**	Inline XBRL Taxonomy Extension Presentation Linkbase
101.DEF	**	Inline XBRL Taxonomy Extension Definition Linkbase
104		The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

^*				~~Incorporated~~Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Huntsman agrees to furnish supplementally to the SEC a copy of any omitted schedule upon request by ~~Reference~~ the SEC.
~~Exhibit Number~~	~~Exhibit Description~~		~~Form~~	~~Exhibit~~	~~Filing Date~~
~~31.1~~	*	~~Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
~~31.2~~	*	~~Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
~~32.1~~	*	~~Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
~~32.2~~	*	~~Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
~~101.INS~~	*	~~Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document~~
~~101.SCH~~	*	~~Inline XBRL Taxonomy Extension Schema~~
~~101.CAL~~	*	~~Inline XBRL Taxonomy Extension Calculation Linkbase~~
~~101.LAB~~	*	~~Inline XBRL Taxonomy Extension Label Linkbase~~
~~101.PRE~~	*	~~Inline XBRL Taxonomy Extension Presentation Linkbase~~
~~101.DEF~~	*	~~Inline XBRL Taxonomy Extension Definition Linkbase~~
~~104~~		~~The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101~~

Filed herewith

4957

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

Dated: ~~April 28,~~November 4, 2022	HUNTSMAN CORPORATION
	HUNTSMAN INTERNATIONAL LLC

	By:	/s/ PHILIP M. LISTER
		Philip M. Lister
		Executive Vice President and Chief Financial Officer
		and Manager (Principal Financial Officer)

	By:	/s/ STEVEN C. JORGENSEN
		Steven C. Jorgensen
		Vice President and Controller (Authorized Signatory and
		Principal Accounting Officer)

5058